id,evidence_inference_prompt_id,pmcid,outcome,intervention,comparator,outcome_type,intervention_events,intervention_group_size,comparator_events,comparator_group_size,intervention_mean,intervention_standard_deviation,comparator_mean,comparator_standard_deviation,standardized_mean_difference,smd_sampling_variance,log_odds_ratio,lor_sampling_variance,log_risk_ratio,lrr_sampling_variance,notes,is_data_complete,tiktoken_with_attributes_xml_token_num,tiktoken_without_attributes_xml_token_num,split,tiktoken_without_attributes_markdown_token_num,output
562,9836,3496170,P3a latency,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data in figure.,FALSE,2318,1990,TEST,1731,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 15
comparator:
    mean: x
    standard_deviation: x
    group_size: 15
```"
213,2913,5459456,lateral bending for the C2-C4 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,5.8,0.5,5.9,0.7,-0.1554,0.2508,,,,,,TRUE,13404,7477,TEST,5693,"```yaml
intervention:
  mean: 9.8
  standard_deviation: 1.2
  group_size: x
comparator:
  mean: 10.1
  standard_deviation: 1.2
  group_size: x
```"
82,3745,3546023,CD4+/CD8+ ratio,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,29,1.19,0.43,1.03,0.53,0.3277,0.0687,,,,,Values are for week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"```yaml
intervention:
  mean: 1.19
  standard_deviation: 0.43
  group_size: 30
comparator:
  mean: 1.03
  standard_deviation: 0.53
  group_size: 29
```"
92,10164,4173437,Postoperatively hematocrit,Tranexamic acid,Control,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,Had to infer that the group sizes were equal. Data is in table in graphic format.,FALSE,854,745,TEST,637,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 30
comparator:
    mean: x
    standard_deviation: x
    group_size: 30
```"
366,12887,5976949,leptin/adiponectin ratio (LAR),"GDM1 (tight glycaemic targets, fasting blood glucose < 5.1 mmol/L and <7.0 mmol/L postprandial)",control group- normal glucose tolerance,continuous,,20,,25,0.97,1.31,0.72,0.46,0.2624,0.0908,,,,,found in table,TRUE,4402,2905,TEST,2274,"```yaml
intervention:
    mean: 0.97
    standard_deviation: 1.31
    group_size: 20
comparator:
    mean: 0.72
    standard_deviation: 0.46
    group_size: 25
```"
165,615,5062234,The 24 h morphine requirement,Transversus abdominis plane block with 0.375% ropivacaine,local anesthetic infiltration of the port site.,continuous,,21,,21,34.57,14.64,32.76,14.34,0.1225,0.0954,,,,,,TRUE,1345,1148,TEST,971,"```yaml
intervention:
    mean: 34.57
    standard_deviation: 14.64
    group_size: 21
comparator:
    mean: 32.76
    standard_deviation: 14.34
    group_size: 21
```"
322,4726,5539943,Motivational Interviewing (MI) knowledge,Language Enhanced Attention and Focus MI training condition (MI-LEAF),baseline,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: 0.111
    standard_deviation: 0.015
    group_size: 190
```"
574,8565,2952311,Verbal rating scale pain intensity,Acupressure at distal points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,"```yaml
intervention:
  mean: 1.7
  standard_deviation: 0.8
  group_size: 11
comparator:
  mean: 1.8
  standard_deviation: 0.6
  group_size: 11
```"
663,13295,4987981,percentage of patients achieving 75 % reduction in PASI and ESI scores,metformin or pioglitazone,placebo,continuous,,37,,23,,,,,cannot calculate,cannot calculate,,,,,Values combined and given in figure,FALSE,9637,7894,TEST,5779,"```yaml
intervention:
  mean: x
  standard_deviation: x
  group_size: 37
comparator:
  mean: x
  standard_deviation: x
  group_size: 23
```"
271,2991,3214395,laryngoscopy failure,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 48",group 3 involved bispectral index (BIS) of 38,continuous,,60,,30,,,,,cannot calculate,cannot calculate,,,,,mean and std not given for group 1 and 2 combined,FALSE,1201,996,TEST,880,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
11,9681,2363753,Glomerular filtration rate fall,Amifostine,Control,continuous,,20,,20,10,,37,,cannot calculate,cannot calculate,,,,,Only abstract is available. Full text in PDF only.,FALSE,887,780,TEST,725,"```yaml
intervention:
    mean: 95
    standard_deviation: x
    group_size: 20
comparator:
    mean: 67
    standard_deviation: x
    group_size: 20
```"
480,4801,5515881,VO2peak,demanding balance training program,relaxation group,continuous,,,,,32.07,6.52,31.947,7.89,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,2868,"```yaml
intervention:
  mean: 32.07
  standard_deviation: 6.52
  group_size: 20
comparator:
  mean: 31.947
  standard_deviation: 7.89
  group_size: 20
```"
293,6104,4215531,MCCB performance : Verbal Learning,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,47.1,10,47.3,10.4,-0.0192,0.1053,,,,,used post values and Treatment as Usual as Baseline,TRUE,7352,5561,TEST,4156,"```yaml
intervention:
  mean: 47.1
  standard_deviation: 10.0
  group_size: 19
comparator:
  mean: 46.2
  standard_deviation: 9.9
  group_size: 19
```"
471,4803,5515881,spatial score,demanding balance training program,relaxation group,continuous,,,,,0.443,0.75,0.04,0.91,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,2868,"```yaml
intervention:
  mean: 0.443
  standard_deviation: 0.75
  group_size: 20
comparator:
  mean: 0.040
  standard_deviation: 0.91
  group_size: 20
```"
544,7792,3508963,Pain score after 5 minutes,Intravenous lidocaine,Intravenous morphine,continuous,,120,,120,3.18,2.27,4.45,2.16,-0.5713783,0.01734682,,,,,,TRUE,3561,2387,TEST,1552,"```yaml
intervention:
    mean: 3.18
    standard_deviation: 2.27
    group_size: 120
comparator:
    mean: 4.45
    standard_deviation: 2.16
    group_size: 120
```"
274,6419,3654355,Body weight,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,-17.5,6.1,-0.5,2.8,-3.1892,0.0933,,,,,,TRUE,18948,9604,TEST,6664,"```yaml
intervention:
    mean: -17.5
    standard_deviation: 6.1
    group_size: 71
comparator:
    mean: -0.5
    standard_deviation: 2.8
    group_size: 33
```"
577,8567,2952311,Salivary alpha-amylase,Acupressure at distal points,Acupressure at local points,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,"```yaml
intervention:
    mean: 36.8
    standard_deviation: 27.9
    group_size: 11
comparator:
    mean: 20.0
    standard_deviation: 9.0
    group_size: 11
```"
310,7833,4541185,onset of motor block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,9.83,1.12,10.85,0.79,-1.0388,0.0757,,,,,found in abstract,TRUE,1359,1043,TEST,907,"```yaml
intervention:
    mean: 9.83
    standard_deviation: 1.12
    group_size: 30
comparator:
    mean: 10.85
    standard_deviation: 0.79
    group_size: 30
```"
406,2803,5781260,Movement induced pain (VAS),lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Mean and CI in figure.,FALSE,4385,3505,TEST,2662,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 20
comparator:
    mean: x
    standard_deviation: x
    group_size: 20
```"
316,9843,4928400,Postoperative pain,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,4.3,1,3.6,1.2,0.619,0.1,,,,,,TRUE,4037,2288,TEST,1670,"```yaml
intervention:
  mean: 6.4
  standard_deviation: 1.3
  group_size: 22
comparator:
  mean: 5.1
  standard_deviation: 1.6
  group_size: 20
```"
635,12290,5777645,Mean BMI change,to peer-led structured patient education,conventional care alone,continuous,,,,,-1.65,2.5,0.05,3.2,,,,,,,SDs found in abstract while group sizes and means found in table 2,TRUE,8661,5060,TEST,3738,"```yaml
intervention:
    mean: -1.65
    standard_deviation: 2.5
    group_size: 70
comparator:
    mean: 0.05
    standard_deviation: 3.2
    group_size: 70
```"
334,5081,5617873,Inappropriate speech,Aripiprazole,Placbeo,continuous,,45,,47,-2.2,0.4,-1.5,0.4,-1.7354,0.0599,,,,,"table 2, given as mean change",TRUE,7551,5383,TEST,4396,"```yaml
intervention:
  mean: -2.2
  standard_deviation: 0.4
  group_size: 47
comparator:
  mean: -1.5
  standard_deviation: 0.4
  group_size: 45
```"
22,3245,2972614,Shoulder Pain and Disability Index score,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,48.13,22.1,40.99,20.98,0.325,0.0798,,,,,,TRUE,7041,2968,TEST,1931,"```yaml
intervention:
    mean: 44.33
    standard_deviation: 2.80
    group_size: 30
comparator:
    mean: 36.39
    standard_deviation: 20.53
    group_size: 22
```"
392,1120,3577738,efficiency,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
44,6986,3169777,Plasma endothelin-1 concentrations,macitentan dose of 600 mg,placebo,continuous,,6,,14,,,,,cannot calculate,cannot calculate,,,,,The mean and SD are in bar chart (figure),FALSE,5143,4376,TEST,3326,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 5
comparator:
    mean: x
    standard_deviation: x
    group_size: 14
```"
99,929,4183415,patient adherence,receive text message reminders about what advice to provide when dispensing artemether-lumefantrine (AL).,no text message,continuous,,40,,37,68.3,23.4,69.8,20.9,-0.0668,0.0521,,,,,"Data found in Table 6. Used same values as ""completed treatment",TRUE,10420,7106,TEST,5310,"```yaml
intervention:
    mean: 68.3
    standard_deviation: 23.4
    group_size: 453
comparator:
    mean: 69.8
    standard_deviation: 20.9
    group_size: 451
```"
168,2797,5079604,incremental area under the curve for insulin (AUCi),subjects who remained in remission,patients with hyperglycemia relapse without significant changes in insulin sensitivity (Si),continuous,,28,,20,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,4923,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 28
comparator:
    mean: x
    standard_deviation: x
    group_size: 20
```"
320,4724,5539943,"sustain talk"" (ST)",Language Enhanced Attention and Focus MI training condition (MI-LEAF),baseline,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: 190
```"
438,3261,3475525,Scores on sodium quiz,MTL group,choices group,continuous,,98,,98,93.5,16.4,47.1,21.1,2.44594908,0.03567007,,,,,,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
    mean: 93.5
    standard_deviation: 16.4
    group_size: 98
comparator:
    mean: 47.1
    standard_deviation: 21.1
    group_size: 98
```"
554,9720,3648394,pNN50,10-week yoga program,Control,continuous,,18,,19,20.7,25.3,19.4,18.4,0.05775336,0.10823221,,,,,Numerical values are from Week 11.,TRUE,9556,6245,TEST,4261,"```yaml
intervention:
    mean: 20.7
    standard_deviation: 25.3
    group_size: 18
comparator:
    mean: 19.4
    standard_deviation: 18.4
    group_size: 19
```"
327,5374,5559992,Anxiety,Buprenophine 96 mg,No treatment,continuous,,5,,5,0,0,23.8,13.82,-2.1985,0.6417,,,,,"decided ""no treatment"" meant baseline",TRUE,1146,884,TEST,721,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 5
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
111,9522,4319071,High-energy snack intake,Intervention + targeting environmental-level factors,Control,continuous,,456,,434,2.5,2.76,2.84,2.71,-0.1242,0.0045,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,"```yaml
intervention:
  mean: x
  standard_deviation: x
  group_size: 456
comparator:
  mean: x
  standard_deviation: x
  group_size: 434
```"
613,11584,115849,Serum C-reactive protein,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 353
comparator:
    mean: x
    standard_deviation: x
    group_size: 181
```"
589,11583,115849,Patient global assessment of disease activity,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 353
comparator:
    mean: x
    standard_deviation: x
    group_size: 357
```"
216,2915,5459456,new bone formation around the screws and bone-implant contact (BIC) in both sections,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating,ACVC,continuous,,8,,8,,,,,cannot calculate,cannot calculate,,,,,,FALSE,13404,7477,TEST,5693,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
243,8057,5534041,composite z-scores in autism spectrum disorder (ASD),left dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,0.13,0.82,-0.25,0.71,0.4783,0.1714,,,,,,TRUE,6951,5679,TEST,4357,"```yaml
intervention:
    mean: 0.13
    standard_deviation: 0.82
    group_size: 12
comparator:
    mean: -0.25
    standard_deviation: 0.71
    group_size: 12
```"
650,13097,5976307,awake time,etomidate,propofol based on midazolam,continuous,,62,,62,15.08,10.06,17.07,11.83,-0.1801099,0.03238887,,,,,found in table 2,TRUE,2560,2044,TEST,1751,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 62
comparator:
    mean: x
    standard_deviation: x
    group_size: 62
```"
597,11583,115849,Discontinuation due to lack of efficacy,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 353
comparator:
    mean: x
    standard_deviation: x
    group_size: 357
```"
306,7831,4541185,duration of sensory block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,703.83,42.9,556.38,37.96,3.5929,0.1742,,,,,found in text,TRUE,1359,1043,TEST,907,"```yaml
intervention:
    mean: 703.83
    standard_deviation: 42.90
    group_size: 30
comparator:
    mean: 556.38
    standard_deviation: 37.96
    group_size: 30
```"
351,4494,5874317,Knee flexion (1-rep Max),Bilateral training,Unilateral training,continuous,,9,,9,99.8,10.2,86.8,2.9,1.6509,0.2979,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,"```yaml
intervention:
    mean: 99.8
    standard_deviation: 10.2
    group_size: 9
comparator:
    mean: 86.8
    standard_deviation: 2.9
    group_size: 9
```"
419,3262,3475525,intent of purchase,MTL+caloric intake group,choices group,continuous,,90,,98,3.6,1.5,4.1,1.7,-0.3098034,0.02157045,,,,,Used values for self.,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
    mean: 3.6
    standard_deviation: 1.5
    group_size: 90
comparator:
    mean: 4.1
    standard_deviation: 1.7
    group_size: 98
```"
346,10233,5686687,Need for dipyrone,Resveratrol,Placebo,continuous,,22,,22,1944,1793,625,250,1.0119,0.1025,,,,,found in table,TRUE,7451,3515,TEST,2366,"```yaml
intervention:
    mean: 1944
    standard_deviation: 1793
    group_size: 5
comparator:
    mean: 625
    standard_deviation: 250
    group_size: 5
```"
282,6422,3654355,baseline skeletal muscle mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,38.4,7.9,37.9,7.4,0.0641,0.0444,,,,,,TRUE,18948,9604,TEST,6664,"```yaml
intervention:
    mean: 38.4
    standard_deviation: 7.9
    group_size: 71
comparator:
    mean: 37.9
    standard_deviation: 7.4
    group_size: 33
```"
634,12289,5777645,HbA1c levels,to peer-led structured patient education,conventional care alone,continuous,,70,,70,1.05,2,0.15,1.7,0.48225433,0.02940203,,,,,SDs found in abstract while group sizes and means found in table 2,TRUE,8661,5060,TEST,3738,"```yaml
intervention:
    mean: -1.05
    standard_deviation: 2.0
    group_size: 70
comparator:
    mean: -0.15
    standard_deviation: 1.7
    group_size: 70
```"
620,11603,1863515,absolute neutrophil count at 35 wk gestation,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,5639,,6150,,cannot calculate,cannot calculate,,,,,"means given but no std given, tables and figures in graphic format",FALSE,3963,3457,TEST,3103,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
288,6102,4215531,alpha power,facial affect training (FAT) in 20 daily 1-hour sessions,treatment as usual (TAU),continuous,,19,,19,,,,,cannot calculate,cannot calculate,,,,,"F-values given, not sure how to use them",FALSE,7350,5561,TEST,4156,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 19
comparator:
    mean: x
    standard_deviation: x
    group_size: 19
```"
223,2914,5459456,Rotation stiffness of C2-4,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,0.02,0,1.62,0.47,-4.5509,0.8972,,,,,"Data is from after fatigue test. Original outcome was just ""The stiffness"".",TRUE,13404,7477,TEST,5693,"```yaml
intervention:
  mean: 0.02
  standard_deviation: 0.00
  group_size: x
comparator:
  mean: 1.62
  standard_deviation: 0.47
  group_size: x
```"
160,7711,5056957,BMI z-score at 12months,Multi-component physical activity,Usual PE and sport programmes,continuous,,592,,459,0.61,1.8,0.66,1.69,-0.0285,0.0039,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 592
comparator:
    mean: x
    standard_deviation: x
    group_size: 459
```"
472,5710,3343759,improvment in ANELT by day 21,higher level of education (>12 years),<12 years of education,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Median is reported. Group sizes are only available in methods section.,FALSE,3838,2633,TEST,2065,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
418,3262,3475525,intent of purchase,MTL group,choices group,continuous,,98,,98,3.8,1.4,4.1,1.7,-0.1919025,0.02050211,,,,,Used values for self.,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
  mean: 3.8
  standard_deviation: 1.4
  group_size: 98
comparator:
  mean: 4.1
  standard_deviation: 1.7
  group_size: 98
```"
618,11603,1863515,haemoglobin level at 35 wk gestation,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,10.7,,11.2,,cannot calculate,cannot calculate,,,,,"means given but no std given, tables and figures in graphic format",FALSE,3963,3457,TEST,3103,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 769
comparator:
    mean: x
    standard_deviation: x
    group_size: 667
```"
514,6551,4033571,Seizure median percent improvement in North America,Extended-release oxcarbazepine 1200 mg,Control,continuous,,,,,-34.5,,-13.3,,cannot calculate,cannot calculate,,,,,"Group sizes are only in figure, and SD is not available.",FALSE,8206,5593,TEST,4514,"```yaml
intervention:
    mean: -34.5
    standard_deviation: x
    group_size: x
comparator:
    mean: -13.3
    standard_deviation: x
    group_size: x
```"
141,1272,4880652,the modified Aldrete scores at 60 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean and SD are in table that is in graphic form.,FALSE,1406,1149,TEST,966,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 76
comparator:
    mean: x
    standard_deviation: x
    group_size: 70
```"
78,3740,3546023,tocopherol levels,200 mg/day palmvitee smokers,baseline,continuous,,30,,30,14.11,3.89,11.39,3.06,0.7671,0.0716,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"```yaml
intervention:
  mean: 14.11
  standard_deviation: 3.89
  group_size: 30
comparator:
  mean: 11.58
  standard_deviation: 3.19
  group_size: 28
```"
436,3261,3475525,Scores on sodium quiz,MTL group,No label group,continuous,,98,,99,93.5,16.4,42.6,20.7,2.71359845,0.03899447,,,,,,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
    mean: 93.5
    standard_deviation: 16.4
    group_size: 98
comparator:
    mean: 42.6
    standard_deviation: 20.7
    group_size: 99
```"
102,1886,4188762,heart rate,remifentanil,lidocaine,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 30
comparator:
    mean: x
    standard_deviation: x
    group_size: 30
```"
276,6421,3654355,Visceral fat,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,-82.3,31.6,4.3,22.7,-2.6604,0.0784,,,,,,TRUE,18948,9604,TEST,6664,"```yaml
intervention:
    mean: -82.3
    standard_deviation: 31.6
    group_size: 71
comparator:
    mean: 4.3
    standard_deviation: 22.7
    group_size: 33
```"
159,7710,5056957,BMI reduction at 12 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,592,,459,21.07,6.39,21.27,5.9,-0.0323,0.0039,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 592
comparator:
    mean: x
    standard_deviation: x
    group_size: 459
```"
388,1119,3577738,focused on the social presence elements in terms of duration,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,"```yaml
intervention:
  mean: x
  standard_deviation: x
  group_size: x
comparator:
  mean: x
  standard_deviation: x
  group_size: x
```"
446,4002,4879328,waist circumference,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,-0.89,3.32,0.3,3.54,-0.3450435,0.01866038,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,"```yaml
intervention:
  mean: x
  standard_deviation: x
  group_size: 103
comparator:
  mean: x
  standard_deviation: x
  group_size: 112
```"
211,2913,5459456,inflexion-extension for the C5-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,1.4,0.1,1.4,0.2,0,0.25,,,,,,TRUE,13404,7477,TEST,5693,"```yaml
intervention:
    mean: 1.4
    standard_deviation: 0.1
    group_size: x
comparator:
    mean: 1.4
    standard_deviation: 0.2
    group_size: x
```"
579,8566,2952311,State-Trait Anxiety Inventory-I,Acupressure at distal points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,"```yaml
intervention:
    mean: 43.2
    standard_deviation: 6.8
    group_size: 11
comparator:
    mean: 39.2
    standard_deviation: 9.5
    group_size: 11
```"
278,6422,3654355,Baseline body mass index,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,42.8,4.6,42.8,6.3,0,0.0444,,,,,,TRUE,18948,9604,TEST,6664,"```yaml
intervention:
    mean: 42.8
    standard_deviation: 4.6
    group_size: 71
comparator:
    mean: 42.8
    standard_deviation: 6.3
    group_size: 33
```"
665,13296,4987981,FPG,pioglitazone,placebo,continuous,,16,,23,103.4,28.9,97.6,20.8,0.23275367,0.1066728,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,"```yaml
intervention:
  mean: 20.5
  standard_deviation: 17.4
  group_size: 16
comparator:
  mean: 2.2
  standard_deviation: 10.0
  group_size: 23
```"
163,7713,5056957,BMI z-score at 24 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,560,,425,0.69,1.81,0.71,1.63,-0.0115,0.0041,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,"```yaml
intervention:
    mean: 0.69
    standard_deviation: x
    group_size: 560
comparator:
    mean: 0.71
    standard_deviation: x
    group_size: 425
```"
172,2790,5079604,Hyperglycemia relapse-free survival,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,continuous,,33,,15,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,4923,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 33
comparator:
    mean: x
    standard_deviation: x
    group_size: 15
```"
430,3261,3475525,Scores on the saturated fat quiz,MTL group,choices group,continuous,,98,,98,90.7,20.4,35.7,15.9,2.99563986,0.04330066,,,,,,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
  mean: 90.7
  standard_deviation: 20.4
  group_size: 98
comparator:
  mean: 35.7
  standard_deviation: 15.9
  group_size: 98
```"
185,4338,5122613,Colonic transit time,Digestion-resistant maltodextrin,Placebo,continuous,,29,,28,39.7,22.3,48,25,-0.3459,0.0712,,,,,,TRUE,6184,3742,TEST,2832,"```yaml
intervention:
  mean: 39.7
  standard_deviation: 22.3
  group_size: 29
comparator:
  mean: 48.0
  standard_deviation: 25.0
  group_size: 28
```"
364,12885,5976949,ANGPTL4 expression,"GDM1 (tight glycaemic targets, fasting blood glucose < 5.1 mmol/L and <7.0 mmol/L postprandial)","GDM2 (less tight glycaemic targets, <5.3_mmol/L and <_7.8_mmol/L)",continuous,,20,,21,23.1,25.6,21.5,25.8,0.061,0.0977,,,,,found in table,TRUE,4402,2905,TEST,2274,"```yaml
intervention:
    mean: 23.11
    standard_deviation: 5.71
    group_size: 20
comparator:
    mean: 21.47
    standard_deviation: 5.64
    group_size: 21
```"
662,13294,4987981,"Psoriasis Area and Severity Index (PASI), Erythema, Scaling and Induration (ESI) and Physician global assessment (PGA) scores",metformin or pioglitazone,placebo,continuous,,37,,23,,,,,cannot calculate,cannot calculate,,,,,Values combined and given in figure,FALSE,9637,7894,TEST,5779,"```yaml
intervention:
  mean: x
  standard_deviation: x
  group_size: 34
comparator:
  mean: x
  standard_deviation: x
  group_size: 21
```"
325,5372,5559992,Anxiety,Buprenophine 32 mg,No treatment,continuous,,5,,5,1,2.23,11,8.63,-1.4322,0.5026,,,,,"decided ""no treatment"" meant baseline",TRUE,1146,884,TEST,721,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 5
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
302,3878,4357072,improvement in symptom scores,topical pimecrolimus cream 1%,triamcinolone acetonide oral paste 0.1%,continuous,,15,,15,0.2,0.4,0.8,0.6,-1.1448,0.1552,,,,,significance found in abstract and numbers in results,TRUE,2097,1624,TEST,1385,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 15
comparator:
    mean: x
    standard_deviation: x
    group_size: 15
```"
300,5599,4355974,School days missed for asthma,BostonBreathes system,Control,continuous,,28,,14,-0.2,,-0.4,,cannot calculate,cannot calculate,,,,,"standard deviations not given, means are mean change",FALSE,7450,5464,TEST,3820,"```yaml
intervention:
    mean: -0.2
    standard_deviation: x
    group_size: 28
comparator:
    mean: -0.4
    standard_deviation: x
    group_size: 14
```"
485,5714,3343759,communication ability,very early speech and language therapy (SLT),control,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Unclear outcome.,FALSE,3838,2633,TEST,2065,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 59
comparator:
    mean: x
    standard_deviation: x
    group_size: 55
```"
669,13296,4987981,triglycerides levels,pioglitazone,placebo,continuous,,16,,23,200.1,55.9,181.8,61.3,0.30295813,0.10715497,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,"```yaml
intervention:
  mean: 53.3
  standard_deviation: 36.9
  group_size: 16
comparator:
  mean: 1.1
  standard_deviation: 43.3
  group_size: 23
```"
433,3261,3475525,Scores on sugar quiz,MTL+caloric intake group,No label group,continuous,,90,,99,92.6,15.5,47.2,19.6,2.54502741,0.03834748,,,,,,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
    mean: 92.6
    standard_deviation: 15.5
    group_size: 90
comparator:
    mean: 47.2
    standard_deviation: 19.6
    group_size: 99
```"
26,3244,2972614,Motion range - Shoulder abduction,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,166.66,21.38,172.72,16.67,-0.3054,0.0797,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,"```yaml
intervention:
    mean: 166.66
    standard_deviation: 21.38
    group_size: 30
comparator:
    mean: 172.72
    standard_deviation: 16.67
    group_size: 22
```"
21,3243,2972614,Severity of pain,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,3.76,1.45,4.63,2.1,-0.4889,0.0811,,,,,,TRUE,7041,2968,TEST,1931,"```yaml
intervention:
    mean: 3.76
    standard_deviation: 1.45
    group_size: 30
comparator:
    mean: 4.63
    standard_deviation: 2.10
    group_size: 22
```"
417,3262,3475525,intent of purchase,MTL+caloric intake group,No label group,continuous,,90,,99,3.6,1.4,4.1,1.5,-0.3426709,0.02152276,,,,,Used values for self.,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
    mean: 3.6
    standard_deviation: 1.5
    group_size: 90
comparator:
    mean: 4.1
    standard_deviation: 1.5
    group_size: 99
```"
385,1118,3577738,website use in terms of the number of pages visited,website with social presence elements.,website without social presence elements.,continuous,,,,,7.5,4,8,3.8,cannot calculate,cannot calculate,,,,,Cannot find the group sizes in the text or table.,FALSE,3018,2080,TEST,1653,"```yaml
intervention:
    mean: 7.5
    standard_deviation: 4.0
    group_size: 241
comparator:
    mean: 8.0
    standard_deviation: 3.8
    group_size: 241
```"
204,5497,5380326,Th1/Th2 cytokines,Vitamin D supplementation,Control,continuous,,40,,40,,,,,cannot calculate,cannot calculate,,,,,Unclear outcome numerical values in the RCT. Cannot clearly identify the actual metric or measure for the given outcome.,FALSE,10658,5810,TEST,4260,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 40
comparator:
    mean: x
    standard_deviation: x
    group_size: 40
```"
164,617,5062234,The visual analog scale scores at rest and on coughing,Transversus abdominis plane block with 0.375% ropivacaine,local anesthetic infiltration of the port site.,continuous,,21,,21,,,,,cannot calculate,cannot calculate,,,,,Data found in table in graphic format.,FALSE,1345,1148,TEST,971,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
513,6549,4033571,Overall seizure median percent reduction,Extended-release oxcarbazepine 1200 mg,Control,continuous,,109,,117,-38.3,,-28.7,,cannot calculate,cannot calculate,,,,,SD was not given,FALSE,8206,5593,TEST,4514,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 122
comparator:
    mean: x
    standard_deviation: x
    group_size: 121
```"
298,5597,4355974,Days limited activity from asthma,BostonBreathes system,Control,continuous,,28,,14,-0.2,,-1.8,,cannot calculate,cannot calculate,,,,,"standard deviations not given, means are mean change",FALSE,7450,5464,TEST,3820,"```yaml
intervention:
    mean: -0.2
    standard_deviation: x
    group_size: 28
comparator:
    mean: -1.8
    standard_deviation: x
    group_size: 14
```"
564,9838,3496170,N1 latency,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data in figure.,FALSE,2318,1990,TEST,1731,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 15
comparator:
    mean: x
    standard_deviation: x
    group_size: 15
```"
67,3041,3321528,wrist flexion,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,2880,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 24
comparator:
    mean: x
    standard_deviation: x
    group_size: 28
```"
144,1272,4880652,"diastolic blood pressure at 10, 15, 20 minutes",fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Means in figure 4's graphics.,FALSE,1406,1149,TEST,966,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 76
comparator:
    mean: x
    standard_deviation: x
    group_size: 70
```"
676,13315,4550271,the proportion of patients who tested positive and received (or were prescribed) an ACT,provider-school intervention,control,continuous,,14,,12,56.4,33,64.2,28,-0.2451619,0.15591776,,,,,mean given as percent and std has no unit,TRUE,24886,12978,TEST,8556,"```yaml
intervention:
  mean: 56.4
  standard_deviation: 33
  group_size: 98
comparator:
  mean: 64.2
  standard_deviation: 28
  group_size: 320
```"
462,4431,5726464,Lipid profile: total cholesterol,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 79
comparator:
    mean: x
    standard_deviation: x
    group_size: 86
```"
323,4726,5539943,Motivational Interviewing (MI) knowledge,MI training (MI-AU),baseline,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: 190
```"
656,13176,5773985,subjective onset of action,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,3,1.08,2.92,1.03,0.07461636,0.08005568,,,,,Found in abstract and results,TRUE,2609,2261,TEST,1917,"```yaml
intervention:
  mean: 3.00
  standard_deviation: 1.08
  group_size: 25
comparator:
  mean: 2.92
  standard_deviation: 1.03
  group_size: 25
```"
167,2797,5079604,Disposition index (DI),subjects who remained in remission,patients with hyperglycemia relapse without significant changes in insulin sensitivity (Si),continuous,,28,,20,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,4923,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 28
comparator:
    mean: x
    standard_deviation: x
    group_size: 20
```"
273,2991,3214395,awakening,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 50",group 3 involved bispectral index (BIS) of 40,continuous,,60,,30,,,,,cannot calculate,cannot calculate,,,,,mean and std not given for group 1 and 2 combined,FALSE,1201,996,TEST,880,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
528,6919,4411165,diastolic BP,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,Numerical values are only in the figures.,FALSE,3146,2589,TEST,2336,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 10
comparator:
    mean: x
    standard_deviation: x
    group_size: 10
```"
610,11584,115849,Swollen joint count,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 353
comparator:
    mean: x
    standard_deviation: x
    group_size: 181
```"
356,4710,5884950,objective-SCORAD score,extensively hydrolyzed whey-based formula with short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,extensively hydrolyzed whey-based formula without (control) short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,continuous,,13,,13,,,,,cannot calculate,cannot calculate,,,,,"mean and std not given, only median and interquartile range",FALSE,11712,6635,TEST,5281,"```yaml
intervention:
  mean: x
  standard_deviation: x
  group_size: 16
comparator:
  mean: x
  standard_deviation: x
  group_size: 15
```"
404,2805,5781260,Glutathione peroxidase (GPxP),lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Mean and CI in figure.,FALSE,4385,3505,TEST,2662,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 20
comparator:
    mean: x
    standard_deviation: x
    group_size: 20
```"
390,950,3278655,subsidence,The trabecular metal tibial monoblock component (TM),cemented component.,continuous,,27,,18,-0.38,0.37,-0.04,0.11,-1.1288,0.1068,,,,,Used numerical values for Superior/inferior translation (SD). Numerical values are from 5-year follow up.,TRUE,5463,3510,TEST,2857,"```yaml
intervention:
    mean: -0.38
    standard_deviation: 0.37
    group_size: 27
comparator:
    mean: -0.04
    standard_deviation: 0.11
    group_size: 18
```"
522,6698,5154016,Total drainage volume,Collagen hemostatic sponge,Gelatin sponge,continuous,,30,,30,248.5,18.8,318.5,26.7,-2.9921679,0.14127557,,,,,,TRUE,3046,2156,TEST,1642,"```yaml
intervention:
    mean: 248.5
    standard_deviation: 18.8
    group_size: 30
comparator:
    mean: 318.5
    standard_deviation: 26.7
    group_size: 32
```"
156,13481,5055753,The mean ¬± SD of intraoperatively administered fentany,0.2 mg oral clonidine,2 mg oral midazolam,continuous,,40,,40,105,30.8,165,34.5,-1.817,0.0706,,,,,,TRUE,3292,2470,TEST,2114,"```yaml
intervention:
    mean: 105
    standard_deviation: 30.8
    group_size: 40
comparator:
    mean: 165
    standard_deviation: 34.5
    group_size: 40
```"
464,4431,5726464,Lipid profile: LDL-c,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 79
comparator:
    mean: x
    standard_deviation: x
    group_size: 86
```"
444,8802,4467620,differences in the accuracy,Hot + Cooling conditions,Hot conditions,continuous,,8,,8,,,,,cannot calculate,cannot calculate,,,,,,FALSE,7288,4607,TEST,3858,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
573,8561,5541727,lateral tibial cartilage volume loss,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,-3.7,3.4,-0.8,3.5,-0.8015134,0.27647057,,,,,Values are from 24 months,TRUE,6118,5345,TEST,4032,"```yaml
intervention:
  mean: -3.7
  standard_deviation: 3.4
  group_size: 11
comparator:
  mean: -0.8
  standard_deviation: 3.5
  group_size: 6
```"
571,8559,5541727,SF-36 bodily pain score improvement,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,6118,5345,TEST,4032,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 11
comparator:
    mean: x
    standard_deviation: x
    group_size: 6
```"
455,4422,4483334,Amount of calcium and phosphate on enamel surface,CPP-ACP plus laser (group D),Distilled and deionized water (group A),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Original outcome was ""Amount of calcium and phosphate on enamel surface"" but changed to ""Total weight percentage of calcium"" since this seemed more accurate. All numerical values are in a graphical format of table.",FALSE,1396,1236,TEST,1068,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 20
comparator:
    mean: x
    standard_deviation: x
    group_size: 20
```"
79,3740,3546023,tocotrienol levels,200 mg/day palmvitee smokers,baseline,continuous,,30,,30,587.68,87.5,59.49,4.21,8.4162,0.6569,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"```yaml
intervention:
  mean: 587.68
  standard_deviation: 87.50
  group_size: 30
comparator:
  mean: 59.49
  standard_deviation: 4.21
  group_size: 30
```"
363,12884,5976949,ANGPTL4 expression,"GDM1 (tight glycaemic targets, fasting blood glucose < 5.1 mmol/L and <7.0 mmol/L postprandial)",control group- normal glucose tolerance,continuous,,20,,25,23.1,25.6,98.3,104.6,-0.9238,0.0995,,,,,found in table,TRUE,4402,2905,TEST,2274,"```yaml
intervention:
  mean: 23.11
  standard_deviation: 5.71
  group_size: 20
comparator:
  mean: 98.33
  standard_deviation: 20.92
  group_size: 25
```"
129,4927,4493951,The sedation score recorded in the postanesthesia care unit (PACU) over the 2-h observation period,H0 (saline),"H1(haloperidol 1 mg),",continuous,,50,,49,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,3932,3205,TEST,2434,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 50
comparator:
    mean: x
    standard_deviation: x
    group_size: 49
```"
181,4339,5122613,Left SCTT,Digestion-resistant maltodextrin,Placebo,continuous,,29,,28,10.2,8.6,12.1,9.5,-0.207,0.0706,,,,,Had to do some simple math to get accurate group size.,TRUE,6184,3742,TEST,2832,"```yaml
intervention:
  mean: 10.2
  standard_deviation: 8.6
  group_size: 29
comparator:
  mean: 12.1
  standard_deviation: 9.5
  group_size: 28
```"
517,6695,5154016,24 h drainage volume,Stypro hemostatic sponge,Gelatin sponge,continuous,,30,,30,187.9,82,230.8,75,-0.538859,0.06908641,,,,,,TRUE,3046,2156,TEST,1642,"```yaml
intervention:
  mean: 187.9
  standard_deviation: 82
  group_size: 30
comparator:
  mean: 230.8
  standard_deviation: 75
  group_size: 32
```"
242,8056,5534041,overall working memory (WM) performance in autism spectrum disorder (ASD),left dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,6.2,1.8,4.8,0.9,0.9498,0.1855,,,,,,TRUE,6951,5679,TEST,4357,"```yaml
intervention:
    mean: 0.13
    standard_deviation: 0.82
    group_size: 12
comparator:
    mean: -0.25
    standard_deviation: 0.71
    group_size: 12
```"
569,8557,5541727,Activities of daily living,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,6118,5345,TEST,4032,"```yaml
intervention:
    mean: 82.1
    standard_deviation: 11.0
    group_size: 11
comparator:
    mean: 92.8
    standard_deviation: 6.4
    group_size: 6
```"
458,4425,4483334,Total weight percentage of phosphate,CPP-ACP plus laser (group D),Distilled and deionized water (group A),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,All numerical values are in a graphical format of table.,FALSE,1396,1236,TEST,1068,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
72,3042,3321528,the total MRC score of the legs,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,2880,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 24
comparator:
    mean: x
    standard_deviation: x
    group_size: 28
```"
295,6104,4215531,MCCB performance : Social Cognition,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,39.3,11.1,42.8,11.7,-0.3005,0.1065,,,,,used post values and Treatment as Usual as Baseline,TRUE,7350,5561,TEST,4156,"```yaml
intervention:
  mean: 39.3
  standard_deviation: 10.4
  group_size: 19
comparator:
  mean: 39.3
  standard_deviation: 11.1
  group_size: 19
```"
23,3247,2972614,Laboratory parameters,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,,,,,cannot calculate,cannot calculate,,,,,Unclear outcome and also no numerical data for this specific outcome,FALSE,7041,2968,TEST,1931,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 30
comparator:
    mean: x
    standard_deviation: x
    group_size: 22
```"
413,3262,3475525,Taste perception,MTL+caloric intake group,No label group,continuous,,90,,99,5.4,1.4,5.8,1.4,-0.2845666,0.02142635,,,,,,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
  mean: 5.4
  standard_deviation: 1.4
  group_size: 90
comparator:
  mean: 5.8
  standard_deviation: 1.4
  group_size: 99
```"
682,13506,5777419,attachment gain,antibiotic,placebo,continuous,,16,,15,4.1,1,4.3,1.4,-0.1610069,0.12958478,,,,,found in table 2,TRUE,9410,4699,TEST,3181,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 16
comparator:
    mean: x
    standard_deviation: x
    group_size: 15
```"
550,9719,3648394,LF:HF component of HRV,10-week yoga program,Control,continuous,,18,,19,0.35,0.43,0.04,0.38,0.74878609,0.1157639,,,,,Numerical values are from Week 11.,TRUE,9556,6245,TEST,4261,"```yaml
intervention:
  mean: 0.35
  standard_deviation: 0.43
  group_size: 17
comparator:
  mean: 0.04
  standard_deviation: 0.38
  group_size: 17
```"
240,8055,5534041,overall working memory (WM) performance in autism spectrum disorder (ASD),right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,6,0.9,4.8,0.9,1.2873,0.2012,,,,,,TRUE,6951,5679,TEST,4357,"```yaml
intervention:
  mean: 0.11
  standard_deviation: 0.81
  group_size: 12
comparator:
  mean: -0.25
  standard_deviation: 0.71
  group_size: 12
```"
486,6382,3786549,Improvement in Vaginal Maturation Index,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,35.2,21.7,9.9,14.5,1.35893992,0.05594726,,,,,Numerical values based on intention-to-treat,TRUE,9725,6231,TEST,4323,"```yaml
intervention:
  mean: 35.2
  standard_deviation: 21.7
  group_size: 44
comparator:
  mean: 9.9
  standard_deviation: 14.5
  group_size: 44
```"
336,5083,5617873,Compulsion scale,Aripiprazole,Placbeo,continuous,,45,,47,-1.3,0.5,-2,0.5,1.3883,0.054,,,,,"table 2, given as mean change",TRUE,7551,5383,TEST,4396,"```yaml
intervention:
    mean: -2.0
    standard_deviation: x
    group_size: 47
comparator:
    mean: -1.3
    standard_deviation: x
    group_size: 45
```"
126,4926,4493951,The sedation score recorded in the postanesthesia care unit (PACU) over the 2-h observation period,and H2 (haloperidol 2 mg),H1(haloperidol 1 mg),continuous,,50,,49,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,3932,3205,TEST,2434,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 50
comparator:
    mean: x
    standard_deviation: x
    group_size: 49
```"
629,12234,3510731,Median time in seconds (interquartile range) - Results link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,continuous,,6051,,5892,25,,25.3,,cannot calculate,cannot calculate,,,,,"found in table 1, IQ range given rather and std",FALSE,1665,1296,TEST,943,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 6051
comparator:
    mean: x
    standard_deviation: x
    group_size: 5892
```"
553,9725,3648394,Quality of life - MCS (SF36),10-week yoga program,Control,continuous,,18,,19,47.5,10.6,48.5,7.7,-0.1060797,0.1083392,,,,,"Original outcome was just ""Quality of Life"". Numerical values are from Week 11.",TRUE,9556,6245,TEST,4261,"```yaml
intervention:
    mean: 47.5
    standard_deviation: 10.6
    group_size: 17
comparator:
    mean: 48.5
    standard_deviation: 7.7
    group_size: 17
```"
136,2448,4574984,postoperative in-hospital stay,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",continuous,,326,,326,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,12997,7944,TEST,5795,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 326
comparator:
    mean: x
    standard_deviation: x
    group_size: 326
```"
646,13025,4675066,The mean language score on the Bayley-III,iodine (150 μg/d),placebo,continuous,,27,,26,97.2,12.2,97.9,11.5,-0.058139,0.07553046,,,,,found in table 2,TRUE,6682,5735,TEST,4224,"```yaml
intervention:
    mean: 97.2
    standard_deviation: 12.2
    group_size: 27
comparator:
    mean: 97.9
    standard_deviation: 11.5
    group_size: 26
```"
402,2804,5781260,Exercise-induced Creatine kinase (CK),lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Mean and CI in figure.,FALSE,4385,3505,TEST,2662,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 20
comparator:
    mean: x
    standard_deviation: x
    group_size: 20
```"
8,9683,2363753,Days with fever,Amifostine,Control,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Only abstract is available. Full text in PDF only.,FALSE,887,780,TEST,725,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 20
comparator:
    mean: x
    standard_deviation: x
    group_size: 20
```"
520,6696,5154016,24 h drainage volume,Collagen hemostatic sponge,Gelatin sponge,continuous,,30,,30,185.2,68,230.8,75,-0.6287208,0.06996075,,,,,,TRUE,3046,2156,TEST,1642,"```yaml
intervention:
    mean: 185.2
    standard_deviation: 68
    group_size: 30
comparator:
    mean: 230.8
    standard_deviation: 75
    group_size: 32
```"
331,5078,5617873,Parent-rated Aberrant Behavior Checklis improvement,Aripiprazole,Placbeo,continuous,,45,,47,-11.4,1.3,-7.5,1.4,-2.8604,0.088,,,,,"all means and std found in table 2, given as mean change from baseline",TRUE,7551,5383,TEST,4396,"```yaml
intervention:
    mean: -11.4
    standard_deviation: 1.3
    group_size: 47
comparator:
    mean: -7.5
    standard_deviation: 1.4
    group_size: 45
```"
409,3260,3475525,Correct selection of the healthier product,MTL+caloric intake group,TL+SNL group,continuous,,90,,95,73.3,6.9,65.8,7.3,1.05077696,0.02462157,,,,,Available in abstract and table,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
  mean: 73.3
  standard_deviation: 6.9
  group_size: 90
comparator:
  mean: 65.8
  standard_deviation: 7.3
  group_size: 95
```"
143,1272,4880652,"oxygen saturation at 10, 15, 20 minutes",fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Means in figure 5's graphics.,FALSE,1406,1149,TEST,966,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 76
comparator:
    mean: x
    standard_deviation: x
    group_size: 70
```"
394,1120,3577738,enjoyment,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
456,4423,4483334,Total weight percentage of calcium,CPP-ACP plus laser (group D),Nd:YAG laser (group B),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Original outcome was ""Amount of calcium and phosphate on enamel surface"" but changed to ""Total weight percentage of calcium"" since this seemed more accurate. All numerical values are in a graphical format of table.",FALSE,1396,1236,TEST,1068,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 20
comparator:
    mean: x
    standard_deviation: x
    group_size: 20
```"
296,5595,4355974,Days of wheeze,BostonBreathes system,Control,continuous,,28,,14,-1.4,,-4.2,,cannot calculate,cannot calculate,,,,,standard deviations not given and means are mean change,FALSE,7450,5464,TEST,3820,"```yaml
intervention:
  mean: -1.4
  standard_deviation: x
  group_size: 28
comparator:
  mean: -4.2
  standard_deviation: x
  group_size: 14
```"
420,3401,3877023,quantitative contour sharpness of the Cervicothoracic Spine,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,18,,21,0.95,0.24,1.43,0.48,-1.2099846,0.12194464,,,,,"Original outcome was ""quantitative contour sharpness"".",TRUE,17694,9686,TEST,7100,"```yaml
intervention:
    mean: 0.8
    standard_deviation: 0.1
    group_size: 18
comparator:
    mean: 1.1
    standard_deviation: 0.2
    group_size: 21
```"
545,8460,3263860,HbA1c reduction,Real-Time Continuous Glucose Monitoring,Control,continuous,,69,,68,-0.1,0.6,-0.1,0.6,0,0.02919864,,,,,Mean change,TRUE,3178,2587,TEST,2232,"```yaml
intervention:
    mean: -0.1
    standard_deviation: 0.6
    group_size: 69
comparator:
    mean: -0.1
    standard_deviation: 0.6
    group_size: 68
```"
640,12772,4511433,LDL cholesterol,2.5 mg,placebo,continuous,,12,,12,,,,,cannot calculate,cannot calculate,,,,,no raw values given and can only be estimated from figure,FALSE,4648,3874,TEST,2969,"```yaml
intervention:
  mean: x
  standard_deviation: x
  group_size: 12
comparator:
  mean: x
  standard_deviation: x
  group_size: 12
```"
119,2981,4323894,Improvement in Glasgow outcome score at 6 months post-trauma,Mild-cooling,No cooling,continuous,,10,,13,70,,15.4,,cannot calculate,cannot calculate,,,,,,FALSE,3049,2670,TEST,2328,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 10
comparator:
    mean: x
    standard_deviation: x
    group_size: 13
```"
281,6422,3654355,baseline fat-free mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,68.3,13.2,67.1,12.8,0.0911,0.0444,,,,,,TRUE,18948,9604,TEST,6664,"```yaml
intervention:
    mean: 68.3
    standard_deviation: 13.2
    group_size: 71
comparator:
    mean: 67.1
    standard_deviation: 12.8
    group_size: 33
```"
217,2912,5459456,surgery time,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,67,16,65,13,0.1297,0.2505,,,,,,TRUE,13404,7477,TEST,5693,"```yaml
intervention:
  mean: 67
  standard_deviation: 16
  group_size: x
comparator:
  mean: 65
  standard_deviation: 13
  group_size: x
```"
586,11522,547916,matrix metalloproteinase-9 (MMP-9),doxycycline (100 mg),placebo,continuous,,10,,4,2.18,1.94,3.26,3.58,-0.4117458,0.35605481,,,,,found in abstract,TRUE,4542,3636,TEST,2822,"```yaml
intervention:
    mean: 2.18
    standard_deviation: 1.94
    group_size: 10
comparator:
    mean: 3.26
    standard_deviation: 3.58
    group_size: 4
```"
268,2991,3214395,laryngoscopy duration,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 45",group 3 involved bispectral index (BIS) of 35,continuous,,60,,30,,,,,cannot calculate,cannot calculate,,,,,mean and std not given for group 1 and 2 combined,FALSE,1201,996,TEST,880,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
415,3262,3475525,Taste perception,MTL+caloric intake group,choices group,continuous,,90,,98,5.4,1.4,5.3,1.5,0.06854473,0.02132769,,,,,,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
    mean: 5.4
    standard_deviation: 1.4
    group_size: 90
comparator:
    mean: 5.3
    standard_deviation: 1.5
    group_size: 98
```"
685,13760,2836833,Fecal fat loss,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,cannot calculate,cannot calculate,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,12992,7163,TEST,5694,"```yaml
intervention:
    mean: 3.0
    standard_deviation: x
    group_size: 34
comparator:
    mean: x
    standard_deviation: x
    group_size: 34
```"
244,10306,5571493,Glycemic level,Dw 5% with Quinine infusion,Dw 5% without Quinine infusion,continuous,,10,,10,0.82,0.05,0.92,0.07,-1.5744,0.262,,,,,,TRUE,1507,1019,TEST,928,"```yaml
intervention:
    mean: 82
    standard_deviation: 5
    group_size: 10
comparator:
    mean: 92
    standard_deviation: 7
    group_size: 10
```"
674,13314,4550271,treatment according to guidelines,provider-school intervention,control,continuous,,14,,12,23.5,26,22.6,23,0.035327,0.1547859,,,,,mean given as percent and std has no unit,TRUE,24886,12978,TEST,8556,"```yaml
intervention:
  mean: 23.5
  standard_deviation: 26
  group_size: 1496
comparator:
  mean: 22.6
  standard_deviation: 23
  group_size: 1536
```"
348,10235,5686687,Prolactin levels,Resveratrol,Placebo,continuous,,22,,22,,,,,cannot calculate,cannot calculate,,,,,median and ranges given,FALSE,7451,3515,TEST,2366,"```yaml
intervention:
    mean: 12
    standard_deviation: x
    group_size: 22
comparator:
    mean: 11.1
    standard_deviation: x
    group_size: 22
```"
312,7835,4541185,drop in mean arterial pressure,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,91.2,6.62,92.04,7.15,-0.1203,0.0668,,,,,found in table,TRUE,1359,1043,TEST,907,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 30
comparator:
    mean: x
    standard_deviation: x
    group_size: 30
```"
255,10572,5711682,In-stent late lumen loss at 9 months,Genoss drug-eluting stent (DES),Promus Element,continuous,,38,,39,0.11,0.25,0.16,0.43,-0.1361,0.2005,,,,,,TRUE,13148,4660,TEST,2966,"```yaml
intervention:
    mean: 0.11
    standard_deviation: 0.25
    group_size: 38
comparator:
    mean: 0.16
    standard_deviation: 0.43
    group_size: 39
```"
32,5580,3003523,Pain,Certolizumab 400 mg,Control,continuous,,390,,199,53.9,22.2,34,20.1,0.9238,0.0083,,,,,Used values for weeks 52 (final timepoint).,TRUE,12247,10091,TEST,7520,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 390
comparator:
    mean: 63.6
    standard_deviation: 19.9
    group_size: 199
```"
639,12772,4511433,LDL cholesterol,5 mg elobixibat,placebo,continuous,,12,,12,,,,,cannot calculate,cannot calculate,,,,,no raw values given and can only be estimated from figure,FALSE,4648,3874,TEST,2969,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 12
comparator:
    mean: x
    standard_deviation: x
    group_size: 12
```"
35,5579,3003523,Fatigue Assessment Scale improvement,Certolizumab 200 mg,Control,continuous,,393,,199,,,,,cannot calculate,cannot calculate,,,,,Values are in figure.,FALSE,12247,10091,TEST,7520,"```yaml
intervention:
  mean: -2.5
  standard_deviation: x
  group_size: 393
comparator:
  mean: -0.8
  standard_deviation: x
  group_size: 199
```"
214,2913,5459456,lateral bending for the C4-C5 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,2,0.4,1.8,0.2,0.5979,0.2612,,,,,,TRUE,13404,7477,TEST,5693,"```yaml
intervention:
    mean: 2.0
    standard_deviation: 0.4
    group_size: x
comparator:
    mean: 1.8
    standard_deviation: 0.2
    group_size: x
```"
280,6422,3654355,baseline fat mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,60.5,11,60.4,13.5,0.0084,0.0444,,,,,,TRUE,18948,9604,TEST,6664,"```yaml
intervention:
    mean: 60.5
    standard_deviation: 11.0
    group_size: 71
comparator:
    mean: 60.4
    standard_deviation: 13.5
    group_size: 33
```"
440,8803,4467620,decrease in exercise intensity as time elapsed (at time 10),Hot + Cooling conditions,Hot conditions,continuous,,8,,8,114.6,35.6,123.9,30.2,-0.2663137,0.25221634,,,,,Added the last timepoint to the outcome name. Since there are 10 different time points.,TRUE,7288,4607,TEST,3858,"```yaml
intervention:
  mean: 114.6
  standard_deviation: 35.6
  group_size: 8
comparator:
  mean: 123.9
  standard_deviation: 30.2
  group_size: 8
```"
666,13296,4987981,total cholesterol,metformin,placebo,continuous,,21,,23,206.9,36.2,184.4,37.5,0.59900785,0.0951747,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,"```yaml
intervention:
  mean: 21.8
  standard_deviation: 25.2
  group_size: 21
comparator:
  mean: 1.4
  standard_deviation: 29.2
  group_size: 23
```"
487,6383,3786549,Baseline characteristics: menopause,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,13.11,7.02,13,6.94,0.01562115,0.04545593,,,,,,TRUE,9725,6231,TEST,4323,"```yaml
intervention:
  mean: 13.11
  standard_deviation: 7.02
  group_size: x
comparator:
  mean: 13.00
  standard_deviation: 6.94
  group_size: x
```"
443,8801,4467620,accuracy of the cognitive tasks,Exercise - Hot condition,At rest - Hot condition,continuous,,8,,8,,,,,cannot calculate,cannot calculate,,,,,,FALSE,7288,4607,TEST,3858,"```yaml
intervention:
  mean: x
  standard_deviation: x
  group_size: 8
comparator:
  mean: x
  standard_deviation: x
  group_size: 8
```"
248,10309,5571493,QT interval,Dw 5%+ Quinine infusion,Dw 5% without Quinine infusion,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No numerical values are given.,FALSE,1507,1019,TEST,928,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 10
comparator:
    mean: x
    standard_deviation: x
    group_size: 10
```"
503,6485,5419060,Phlebotomy questionnaire score: CHC A,Phlebotomy training programme,Control,continuous,,23,,23,96,3.89,63,12.31,3.55292234,0.22416584,,,,,Back calculated SD using CI,TRUE,9292,5719,TEST,4155,"```yaml
intervention:
    mean: 96
    standard_deviation: 1.59
    group_size: x
comparator:
    mean: 63
    standard_deviation: 5.03
    group_size: x
```"
686,13761,2836833,Urinary calcium excretion,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,cannot calculate,cannot calculate,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,12992,7163,TEST,5694,"```yaml
intervention:
  mean: 145.65
  standard_deviation: 72.7
  group_size: x
comparator:
  mean: 128.55
  standard_deviation: 51.45
  group_size: x
```"
466,4433,5726464,Changes in body mass index,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 79
comparator:
    mean: x
    standard_deviation: x
    group_size: 86
```"
636,12291,5777645,Mean waist circumference,to peer-led structured patient education,conventional care alone,continuous,,,,,-3.34,9.3,2.65,10.3,,,,,,,SDs found in abstract while group sizes and means found in table 2,TRUE,8661,5060,TEST,3738,"```yaml
intervention:
  mean: -3.34
  standard_deviation: 9.3
  group_size: 70
comparator:
  mean: 2.65
  standard_deviation: 10.3
  group_size: 70
```"
615,11602,1863515,haemoglobin level between 26 and 35 wk,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,-0.4,,0,,cannot calculate,cannot calculate,,,,,"given as estimated change and no std given, also in figure and graphic format",FALSE,3963,3457,TEST,3103,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 769
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
600,11583,115849,Tender joint count,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 181
comparator:
    mean: x
    standard_deviation: x
    group_size: 357
```"
29,3244,2972614,Motion range - Shoulder external rotation,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,44.83,5.64,44.09,1.97,0.1626,0.079,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,"```yaml
intervention:
    mean: 44.83
    standard_deviation: 5.64
    group_size: 30
comparator:
    mean: 44.09
    standard_deviation: 1.97
    group_size: 22
```"
104,1885,4188762,mean blood pressure,remifentanil,normal saline,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 30
comparator:
    mean: x
    standard_deviation: x
    group_size: 30
```"
142,1272,4880652,systolic pressures at 0 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean in figure 3's graphics.,FALSE,1406,1149,TEST,966,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 76
comparator:
    mean: x
    standard_deviation: x
    group_size: 70
```"
332,5079,5617873,Clinician-rated Clinical Global Impression-Improvement scores,Aripiprazole,Placbeo,continuous,,,,,2.4,0.1,3.4,0.1,-9.9164,0.5779,,,,,raw values foun din text,TRUE,7551,5383,TEST,4396,"```yaml
intervention:
    mean: 2.7
    standard_deviation: 0.1
    group_size: 47
comparator:
    mean: 3.4
    standard_deviation: 0.1
    group_size: 45
```"
80,3740,3546023,tocopherol levels,200 mg/day palmvitee nonsmokers,baseline,continuous,,29,,29,14.56,3.06,11.75,2.27,1.029,0.0781,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"```yaml
intervention:
  mean: 14.56
  standard_deviation: 3.06
  group_size: 29
comparator:
  mean: 11.67
  standard_deviation: 3.19
  group_size: 27
```"
309,7833,4541185,onset of sensory block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,4.36,0.81,4.84,0.65,-0.6451,0.0701,,,,,found in abstract,TRUE,1359,1043,TEST,907,"```yaml
intervention:
    mean: 4.36
    standard_deviation: 0.81
    group_size: 30
comparator:
    mean: 4.84
    standard_deviation: 0.65
    group_size: 30
```"
287,6100,4215531,alpha power,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,,,,,cannot calculate,cannot calculate,,,,,"F-values given, not sure how to use them",FALSE,7350,5561,TEST,4156,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 19
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
595,11583,115849,Serum C-reactive protein,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 353
comparator:
    mean: x
    standard_deviation: x
    group_size: 357
```"
345,10232,5686687,Pain,Resveratrol,Placebo,continuous,,22,,22,,,,,cannot calculate,cannot calculate,,,,,given as median and range,FALSE,7451,3515,TEST,2366,"```yaml
intervention:
  mean: 3.2
  standard_deviation: x
  group_size: 22
comparator:
  mean: 3.9
  standard_deviation: x
  group_size: 22
```"
536,7795,3508963,Baseline characteristics - age,Intravenous lidocaine,Intravenous morphine,continuous,,120,,120,35.23,12.37,37.71,11.08,-0.2105282,0.016759,,,,,,TRUE,3561,2387,TEST,1552,"```yaml
intervention:
  mean: 35.23
  standard_deviation: 12.37
  group_size: 120
comparator:
  mean: 37.71
  standard_deviation: 11.08
  group_size: 120
```"
602,11583,115849,Patient global assessment of pain,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 181
comparator:
    mean: x
    standard_deviation: x
    group_size: 357
```"
125,4926,4493951,The sedation score recorded in the postanesthesia care unit (PACU) over the 2-h observation period,and H2 (haloperidol 2 mg),H0 (saline),continuous,,50,,50,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,3932,3205,TEST,2434,"```yaml
intervention:
  mean: x
  standard_deviation: x
  group_size: 50
comparator:
  mean: x
  standard_deviation: x
  group_size: 50
```"
171,2793,5079604,The restricted mean time to hyperglycemia relapse,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,continuous,,33,,15,480,,305,,cannot calculate,cannot calculate,,,,,SD is not given.,FALSE,12690,6902,TEST,4923,"```yaml
intervention:
  mean: 480
  standard_deviation: x
  group_size: 33
comparator:
  mean: 305
  standard_deviation: x
  group_size: 15
```"
526,6916,4411165,tympanic temperature from Pre to P20 (-0.28 ±0.11°C),"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,-0.28,0.11,-0.14,0.05,-1.5691765,0.26155787,,,,,Values on mean change are based on what is reported in abstract.,TRUE,3146,2589,TEST,2336,"```yaml
intervention:
    mean: -0.28
    standard_deviation: 0.11
    group_size: 10
comparator:
    mean: -0.14
    standard_deviation: 0.05
    group_size: 10
```"
169,2792,5079604,hyperglycemia relapse-free survival,"metformin 1,000 mg daily",sitagliptin 100 mg daily,continuous,,17,,16,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,4923,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 17
comparator:
    mean: x
    standard_deviation: x
    group_size: 16
```"
601,11583,115849,Swollen joint count,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 181
comparator:
    mean: x
    standard_deviation: x
    group_size: 357
```"
429,3261,3475525,Scores on the saturated fat quiz,MTL+caloric intake group,No label group,continuous,,90,,99,92.3,15.1,33.6,16.3,3.71430281,0.0577096,,,,,,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
    mean: 92.3
    standard_deviation: 15.1
    group_size: 90
comparator:
    mean: 33.6
    standard_deviation: 16.3
    group_size: 99
```"
582,10219,3504298,Attentional Function,Word-based attentional bias modification,Face-based attentional bias modification,continuous,,16,,16,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates, and values in figure",FALSE,4963,4205,TEST,3331,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 31
comparator:
    mean: x
    standard_deviation: x
    group_size: 30
```"
396,1120,3577738,interest,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
441,8804,4467620,weight reduction,Hot + Cooling conditions,Hot conditions,continuous,,8,,8,68.6,7.7,68.8,7.5,-0.0248738,0.25001933,,,,,The numerical values are from Exercise state.,TRUE,7288,4607,TEST,3858,"```yaml
intervention:
    mean: 0.37
    standard_deviation: 0.22
    group_size: 8
comparator:
    mean: 0.41
    standard_deviation: 0.07
    group_size: 8
```"
397,2240,4678179,progression-free-survival (PFS),vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),continuous,,53,,53,,,,,cannot calculate,cannot calculate,,,,,Median was only given.,FALSE,9517,6474,TEST,5204,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 53
comparator:
    mean: x
    standard_deviation: x
    group_size: 53
```"
371,228,1475568,Baseline life-quality score,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,45,,57,,cannot calculate,cannot calculate,,,,,Only the mean score was given in table.,FALSE,4361,3649,TEST,2573,"```yaml
intervention:
    mean: 45
    standard_deviation: x
    group_size: 59
comparator:
    mean: 57
    standard_deviation: x
    group_size: 64
```"
89,5538,3912320,Correct response rate for 500 Hz frequency,Occupational noise,Control,continuous,,19,,10,,,,,cannot calculate,cannot calculate,,,,,Mean were in a figure and SD was not given anywhere.,FALSE,1648,1217,TEST,1015,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 19
comparator:
    mean: x
    standard_deviation: x
    group_size: 10
```"
448,4003,4879328,effects for vigorous activity,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,0.2,1.56,-0.4,2.48,0.28575833,0.0185746,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 104
comparator:
    mean: x
    standard_deviation: x
    group_size: 114
```"
604,11583,115849,Serum C-reactive protein,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 181
comparator:
    mean: x
    standard_deviation: x
    group_size: 357
```"
521,6697,5154016,Total drainage volume,Stypro hemostatic sponge,Gelatin sponge,continuous,,30,,30,231.5,18.1,318.5,26.7,-3.7647135,0.18477557,,,,,,TRUE,3046,2156,TEST,1642,"```yaml
intervention:
  mean: 231.5
  standard_deviation: 18.1
  group_size: 30
comparator:
  mean: 318.5
  standard_deviation: 26.7
  group_size: 32
```"
395,1120,3577738,active trust,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
563,9837,3496170,Self-report questionnaire,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No numerical values are given.,FALSE,2318,1990,TEST,1731,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 15
comparator:
    mean: x
    standard_deviation: x
    group_size: 15
```"
697,5639,5712123,morphine requirements,D/E group,P group,continuous,,30,,30,17.9,3.2,31.9,6.7,-2.6318902,0.12439038,,,,,found in fig3,TRUE,6401,5359,TEST,3891,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 30
comparator:
    mean: x
    standard_deviation: x
    group_size: 30
```"
350,4493,5874317,Knee extension (1-rep Max),Bilateral training,Unilateral training,continuous,,9,,9,237.2,51,182.4,8.4,1.4252,0.2786,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,"```yaml
intervention:
  mean: 237.2
  standard_deviation: 51.0
  group_size: 9
comparator:
  mean: 182.4
  standard_deviation: 8.4
  group_size: 9
```"
695,5639,5712123,morphine requirements,E group,P group,continuous,,30,,30,24.6,4.5,31.9,6.7,-1.2625038,0.0799493,,,,,found in fig3,TRUE,6401,5359,TEST,3891,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 30
comparator:
    mean: x
    standard_deviation: x
    group_size: 30
```"
197,7734,5380284,Pain scores 48 hours after the surgery,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,,FALSE,1731,1429,TEST,1251,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 38
comparator:
    mean: x
    standard_deviation: x
    group_size: 37
```"
34,5578,3003523,Mental Component Summary improvement,Certolizumab 400 mg,Control,continuous,,390,,199,45.4,11.5,41.1,10.8,0.3811,0.0077,,,,,Used values for MCS after 52 weeks (final timepoint).,TRUE,12247,10091,TEST,7520,"```yaml
intervention:
    mean: 6.4
    standard_deviation: x
    group_size: 390
comparator:
    mean: 2.1
    standard_deviation: x
    group_size: 199
```"
335,5082,5617873,Social withdrawal,Aripiprazole,Placbeo,continuous,,45,,47,-4.7,1.1,-5.2,1,0.4722,0.0447,,,,,"table 2, given as mean change",TRUE,7551,5383,TEST,4396,"```yaml
intervention:
    mean: -5.2
    standard_deviation: 1.0
    group_size: 47
comparator:
    mean: -4.7
    standard_deviation: 1.1
    group_size: 45
```"
202,5498,5380326,Interferon gamma-induced protein 10,Vitamin D supplementation,Control,continuous,,40,,40,636.47,448.47,748.88,551,-0.2216,0.0503,,,,,,TRUE,10658,5810,TEST,4260,"```yaml
intervention:
  mean: 636.47
  standard_deviation: 70.91
  group_size: 40
comparator:
  mean: 748.88
  standard_deviation: 87.12
  group_size: 40
```"
399,2242,4678179,Response rates,vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),continuous,,53,,53,8,,13,,cannot calculate,cannot calculate,,,,,Only difference in response rates as percent is given.,FALSE,9517,6474,TEST,5204,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 53
comparator:
    mean: x
    standard_deviation: x
    group_size: 53
```"
603,11583,115849,Health Assessment Questionnaire disability,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 181
comparator:
    mean: x
    standard_deviation: x
    group_size: 357
```"
360,8712,5971365,Symbol Digit Modalities Test (SDMT) score at week 144 in limited patients,daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,continuous,,287,,277,6.3,12.6,3.1,13.2,0.2478,0.0071,,,,,"found in figure and text, totals found in figure",TRUE,3177,2394,TEST,2130,"```yaml
intervention:
    mean: 6.3
    standard_deviation: 12.6
    group_size: 287
comparator:
    mean: 3.1
    standard_deviation: 13.2
    group_size: 277
```"
566,8556,5541727,Knee Injury and Osteoarthritis Outcome Score improvement,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,6118,5345,TEST,4032,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 11
comparator:
    mean: x
    standard_deviation: x
    group_size: 6
```"
693,5636,5712123,postoperative pain at rest,duloxetine 60 and etoricoxib 120mg (group D/E),placebo,continuous,,30,,30,2,,3,,cannot calculate,cannot calculate,,,,,values given as score (range),FALSE,6401,5359,TEST,3891,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 30
comparator:
    mean: x
    standard_deviation: x
    group_size: 30
```"
557,9830,3136370,Fibromyalgia Impact Questionnaire scores,Soy shake,Casein shake (Placebo),continuous,,12,,16,-17.1,68.08,-19.57,93.53,0.02864501,0.14584799,,,,,From per protocol,TRUE,6022,3786,TEST,2937,"```yaml
intervention:
    mean: -8.21
    standard_deviation: x
    group_size: 25
comparator:
    mean: -12.52
    standard_deviation: x
    group_size: 25
```"
465,4431,5726464,Lipid profile: Triglycerides,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 79
comparator:
    mean: x
    standard_deviation: x
    group_size: 86
```"
637,12720,4132222,decrease in average lesion,application of a canola phenolic acid-based cream (CPA),placebo,continuous,,30,,15,,,,,cannot calculate,cannot calculate,,,,,no raw values given and can only be estimated from figure,FALSE,2177,1885,TEST,1617,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 30
comparator:
    mean: x
    standard_deviation: x
    group_size: 15
```"
616,11602,1863515,leucocyte count between 26 and 35 wk,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,-423,,0,,cannot calculate,cannot calculate,,,,,"given as estimated change and no std given, also in figure and graphic format",FALSE,3963,3457,TEST,3103,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 769
comparator:
    mean: x
    standard_deviation: x
    group_size: 667
```"
68,3041,3321528,hip flexion,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,2880,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 24
comparator:
    mean: x
    standard_deviation: x
    group_size: 28
```"
576,8563,2952311,State-Trait Anxiety Inventory-I,Acupressure at local points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,"```yaml
intervention:
    mean: 44.5
    standard_deviation: 8.0
    group_size: 11
comparator:
    mean: 39.2
    standard_deviation: 9.5
    group_size: 11
```"
157,13482,5055753,Mean ± SD of heart rate,0.2 mg oral clonidine,2 mg oral midazolam,continuous,,40,,40,,,,,cannot calculate,cannot calculate,,,,,Info in figure graphics.,FALSE,3292,2470,TEST,2114,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 40
comparator:
    mean: x
    standard_deviation: x
    group_size: 40
```"
468,4802,5515881,memory score,demanding balance training program,relaxation group,continuous,,,,,9.44,5.48,8,4.16,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,2868,"```yaml
intervention:
  mean: 9.44
  standard_deviation: 5.48
  group_size: 20
comparator:
  mean: 8.00
  standard_deviation: 4.16
  group_size: 20
```"
177,10754,5086025,General mental health,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,50.24,7.41,45.63,6.31,0.6598,0.0811,,,,,,TRUE,29049,17627,TEST,13068,"```yaml
intervention:
    mean: 50.24
    standard_deviation: 7.41
    group_size: 26
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
678,13505,5777419,the total cultivable microbiota,antibiotic,placebo,continuous,,16,,15,,,,,cannot calculate,cannot calculate,,,,,median and IQ scores given,FALSE,9410,4699,TEST,3181,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 16
comparator:
    mean: x
    standard_deviation: x
    group_size: 15
```"
54,5309,3195393,Restraint knowledge,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,6.23,,5.51,,cannot calculate,cannot calculate,,,,,No SD information provided,FALSE,15527,8380,TEST,5589,"```yaml
intervention:
    mean: 6.23
    standard_deviation: x
    group_size: x
comparator:
    mean: 5.51
    standard_deviation: x
    group_size: x
```"
449,4004,4879328,FFBQ Total Index Score,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,0.07,0.26,0.01,0.33,0.20018961,0.01847923,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 104
comparator:
    mean: x
    standard_deviation: x
    group_size: 114
```"
285,6302,3929816,Pathologic changes in the liver,Intraabdominal pressure 20 mm Hg,Intraabdominal pressure 12 mm Hg,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No quantitative measures given,FALSE,1047,859,TEST,749,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 10
comparator:
    mean: x
    standard_deviation: x
    group_size: 10
```"
643,12880,5830087,duration of objective response,"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),continuous,,48,,23,,,,,cannot calculate,cannot calculate,,,,,"given as median with confidence interval, cannot calculate",FALSE,11942,10628,TEST,8141,"```yaml
intervention:
    mean: 10.3
    standard_deviation: x
    group_size: 29
comparator:
    mean: 5.6
    standard_deviation: x
    group_size: 10
```"
672,13313,4550271,Community knowledge,provider-school intervention,control,continuous,,14,,12,,,,,cannot calculate,cannot calculate,,,,,outcome too broad,FALSE,24886,12978,TEST,8556,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 413
comparator:
    mean: x
    standard_deviation: x
    group_size: 382
```"
592,11583,115849,Swollen joint count,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 353
comparator:
    mean: x
    standard_deviation: x
    group_size: 357
```"
354,4497,5874317,Horizontal countermovement jump,Bilateral training,Unilateral training,continuous,,9,,9,2.34,0.07,2.21,0.15,1.0576,0.2533,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,"```yaml
intervention:
  mean: 0.40
  standard_deviation: 0.05
  group_size: 9
comparator:
  mean: 0.40
  standard_deviation: 0.05
  group_size: 9
```"
598,11583,115849,Patient global assessment of disease activity,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 181
comparator:
    mean: x
    standard_deviation: x
    group_size: 357
```"
180,10757,5086025,General physical health,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,50.87,11.02,50.46,7.83,0.0422,0.0769,,,,,,TRUE,29049,17627,TEST,13068,"```yaml
intervention:
  mean: x
  standard_deviation: x
  group_size: x
comparator:
  mean: x
  standard_deviation: x
  group_size: x
```"
452,4001,4879328,weight loss,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,-0.89,3.33,0.3,3.54,-0.3445812,0.01865965,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,"```yaml
intervention:
    mean: -0.89
    standard_deviation: x
    group_size: 104
comparator:
    mean: 0.30
    standard_deviation: x
    group_size: 114
```"
161,7712,5056957,Weight reduction at 24 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,560,,425,61.08,15.15,61.94,14.25,-0.0582,0.0041,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,"```yaml
intervention:
  mean: 61.08
  standard_deviation: x
  group_size: 560
comparator:
  mean: 61.94
  standard_deviation: x
  group_size: 425
```"
645,13025,4675066,The mean cognitive score on the Bayley-III,iodine (150 μg/d),placebo,continuous,,27,,26,99.4,12.2,101.7,8.2,-0.2172012,0.07594364,,,,,found in table 2,TRUE,6682,5735,TEST,4224,"```yaml
intervention:
  mean: 99.4
  standard_deviation: 12.2
  group_size: 27
comparator:
  mean: 101.7
  standard_deviation: 8.2
  group_size: 26
```"
286,6303,3929816,Pathologic changes in the kidneys,Intraabdominal pressure 20 mm Hg,Intraabdominal pressure 12 mm Hg,continuous,,10,,10,20,,,,cannot calculate,cannot calculate,,,,,Not enough measures given for calculation,FALSE,1047,859,TEST,749,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 10
comparator:
    mean: x
    standard_deviation: x
    group_size: 10
```"
421,3401,3877023,quantitative contour sharpness of the thoracolumbar spine,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,30,,34,0.83,0.22,1.32,0.51,-1.2060514,0.07410885,,,,,"Original outcome was ""quantitative contour sharpness"".",TRUE,17694,9686,TEST,7100,"```yaml
intervention:
  mean: 0.6
  standard_deviation: 0.1
  group_size: 49
comparator:
  mean: 1
  standard_deviation: 0.3
  group_size: 54
```"
518,6699,5154016,Second 24 h drainage volume,Stypro hemostatic sponge,Gelatin sponge,continuous,,30,,30,53.7,3.8,63.5,14.2,-0.9305774,0.07388312,,,,,,TRUE,3046,2156,TEST,1642,"```yaml
intervention:
    mean: 53.7
    standard_deviation: 3.8
    group_size: 30
comparator:
    mean: 63.5
    standard_deviation: 14.2
    group_size: 32
```"
97,10168,4173437,Crystalloid solution needed,Tranexamic acid,Control,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,Had to infer that the group sizes were equal. No numerical values associated with this outcome.,FALSE,854,745,TEST,637,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 30
comparator:
    mean: x
    standard_deviation: x
    group_size: 30
```"
179,10756,5086025,BMI,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,32.81,5.31,32.93,4.85,-0.0232,0.0769,,,,,,TRUE,29049,17627,TEST,13068,"```yaml
intervention:
    mean: 32.81
    standard_deviation: 5.31
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
330,5377,5559992,Anxiety,Buprenophine 64 mg,Buprenophine 96 mg,continuous,,4,,5,1.25,2.5,0,0,0.6784,0.4756,,,,,found in table,TRUE,1146,884,TEST,721,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 4
comparator:
    mean: x
    standard_deviation: x
    group_size: 5
```"
386,1118,3577738,website use in terms of time on the website,website with social presence elements.,website without social presence elements.,continuous,,,,,151,117.4,150.8,107.8,cannot calculate,cannot calculate,,,,,Cannot find the group sizes in the text or table.,FALSE,3018,2080,TEST,1653,"```yaml
intervention:
    mean: 151.0
    standard_deviation: 117.4
    group_size: 241
comparator:
    mean: 150.8
    standard_deviation: 107.8
    group_size: 241
```"
324,4727,5539943,Motivational Interviewing (MI) knowledge,Language Enhanced Attention and Focus MI training condition (MI-LEAF),MI training (MI-AU),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
114,9523,4319071,Fruit intake,Intervention + targeting environmental-level factors,Control,continuous,,456,,434,2.17,1.71,2,1.67,0.1005,0.0045,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,"```yaml
intervention:
    mean: 2.17
    standard_deviation: x
    group_size: 456
comparator:
    mean: 2.00
    standard_deviation: x
    group_size: 434
```"
205,5500,5380326,Interleukin 2,Vitamin D supplementation,Control,continuous,,40,,40,4.49,13.34,28.69,103.03,-0.2276,0.0503,,,,,,TRUE,10658,5810,TEST,4260,"```yaml
intervention:
    mean: 4.49
    standard_deviation: x
    group_size: 40
comparator:
    mean: 28.69
    standard_deviation: x
    group_size: 40
```"
246,10305,5571493,Glycemic level,Saline + Quinine infusion,Saline without Quinine infusion,continuous,,10,,10,0.74,0.05,0.83,0.05,-1.7238,0.2743,,,,,,TRUE,1507,1019,TEST,928,"```yaml
intervention:
    mean: 74
    standard_deviation: 5
    group_size: 10
comparator:
    mean: 83
    standard_deviation: 5
    group_size: 10
```"
245,10307,5571493,Glycemic level,Saline + Quinine infusion,Dw 5% + Quinine infusion,continuous,,10,,10,0.74,0.05,0.82,0.05,-1.5322,0.2587,,,,,,TRUE,1507,1019,TEST,928,"```yaml
intervention:
    mean: 74
    standard_deviation: 5
    group_size: 10
comparator:
    mean: 82
    standard_deviation: 5
    group_size: 10
```"
359,8711,5971365,Symbol Digit Modalities Test (SDMT) score at week 96,daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,continuous,,720,,682,4.1,12.4,2.9,12.7,0.0956,0.0029,,,,,"found in figure and text, totals found in figure",TRUE,3177,2394,TEST,2130,"```yaml
intervention:
  mean: 4.1
  standard_deviation: 12.4
  group_size: 919
comparator:
  mean: 2.9
  standard_deviation: 12.7
  group_size: 922
```"
489,6383,3786549,Baseline characteristics: weight,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,56.16,8.1,57.82,8.24,-0.201397,0.045685,,,,,,TRUE,9725,6231,TEST,4323,"```yaml
intervention:
    mean: 56.16
    standard_deviation: 8.10
    group_size: 44
comparator:
    mean: 57.82
    standard_deviation: 8.24
    group_size: 44
```"
445,4098,4140238,ocular itching for visit 3B at 7 min,bepotastine besilate ophthalmic solution (BBOS) 1.5%,placebo,continuous,,70,,70,1.2,,2.1,,cannot calculate,cannot calculate,,,,,"Original outcome name is ""ocular itching"". However, due to many different visits and data from timepoints. We specified this in the outcome. Visit 3B was the first study they conducted and 7 min is the last timepoint. No SD information was given",FALSE,12685,6812,TEST,5052,"```yaml
intervention:
    mean: 1.2
    standard_deviation: x
    group_size: 68
comparator:
    mean: 2.0
    standard_deviation: x
    group_size: 70
```"
556,9828,3136370,Fibromyalgia Impact Questionnaire scores,Soy shake,Control,continuous,,12,,16,-17.1,68.08,-19.57,93.53,0.02864501,0.14584799,,,,,From per protocol,TRUE,6022,3786,TEST,2937,"```yaml
intervention:
  mean: -8.21
  standard_deviation: x
  group_size: 25
comparator:
  mean: -12.52
  standard_deviation: x
  group_size: 25
```"
688,13763,2836833,systolic or diastolic blood pressure,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,cannot calculate,cannot calculate,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,12992,7163,TEST,5694,"```yaml
intervention:
  mean: x
  standard_deviation: x
  group_size: x
comparator:
  mean: x
  standard_deviation: x
  group_size: x
```"
459,4425,4483334,Total weight percentage of phosphate,CPP-ACP plus laser (group D),Nd:YAG laser (group B),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,All numerical values are in a graphical format of table.,FALSE,1396,1236,TEST,1068,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
208,2913,5459456,inflexion-extension for the C2-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,6.3,1.1,6.5,0.9,-0.1881,0.2511,,,,,,TRUE,13404,7477,TEST,5693,"```yaml
intervention:
    mean: 6.3
    standard_deviation: 1.1
    group_size: x
comparator:
    mean: 6.5
    standard_deviation: 0.9
    group_size: x
```"
289,6103,4215531,MCCB performance : Processing Speed,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,44.6,12.2,48.2,12.3,-0.2877,0.1064,,,,,used post values and Treatment as Usual as Baseline,TRUE,7350,5561,TEST,4156,"```yaml
intervention:
  mean: 44.6
  standard_deviation: 12.2
  group_size: 19
comparator:
  mean: 39.5
  standard_deviation: 10.6
  group_size: 19
```"
567,8560,5541727,Tibial bone expansion,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,-0.7,1.5,1,1.1,-1.1693949,0.29779588,,,,,"Values are from ""total tibial plateau"" for 24 months",TRUE,6118,5345,TEST,4032,"```yaml
intervention:
    mean: 0.5
    standard_deviation: 2.4
    group_size: 11
comparator:
    mean: 4.0
    standard_deviation: 2.3
    group_size: 6
```"
112,9525,4319071,Vegetable intake,Intervention + targeting environmental-level factors,Control,continuous,,456,,434,167.61,83.71,158.67,78.33,0.1101,0.0045,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,"```yaml
intervention:
    mean: 167.61
    standard_deviation: 3.92
    group_size: 456
comparator:
    mean: 158.67
    standard_deviation: 3.76
    group_size: 434
```"
215,2913,5459456,lateral bending for the C5-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,2.2,0.4,2,0.3,0.5347,0.2589,,,,,,TRUE,13404,7477,TEST,5693,"```yaml
intervention:
  mean: 2.0
  standard_deviation: 0.4
  group_size: x
comparator:
  mean: 2.0
  standard_deviation: 0.3
  group_size: x
```"
33,5575,3003523,Health-related quality of life improvement - Short-Form 36-Items improvement,Certolizumab 200 mg,Control,continuous,,393,,199,38.1,9.5,31.5,7.4,0.7447,0.008,,,,,This outcome is measured by Short-Form 36-Items (SF-36).,TRUE,12247,10091,TEST,7520,"```yaml
intervention:
    mean: 45.8
    standard_deviation: 11.4
    group_size: 393
comparator:
    mean: 41.1
    standard_deviation: 10.8
    group_size: 199
```"
432,3261,3475525,Scores on sugar quiz,MTL group,No label group,continuous,,98,,99,90,20.7,47.2,19.6,2.11539588,0.03166271,,,,,,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
    mean: 90.0
    standard_deviation: 20.7
    group_size: 98
comparator:
    mean: 47.2
    standard_deviation: 19.6
    group_size: 99
```"
353,4496,5874317,Squat jump,Bilateral training,Unilateral training,continuous,,9,,9,0.37,0.04,0.34,0.04,0.7142,0.2364,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,"```yaml
intervention:
  mean: 0.37
  standard_deviation: 0.04
  group_size: 9
comparator:
  mean: 0.34
  standard_deviation: 0.04
  group_size: 9
```"
560,9834,3496170,Learned irrelevance index,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data in figure.,FALSE,2318,1990,TEST,1731,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 15
comparator:
    mean: x
    standard_deviation: x
    group_size: 15
```"
75,3743,3546023,The percentage of B cells,200 mg/day palmvitee nonsmokers,baseline,continuous,,29,,29,11.97,4,13.72,4.53,-0.404,0.0704,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"```yaml
intervention:
    mean: 13.72
    standard_deviation: 4.53
    group_size: 29
comparator:
    mean: 11.13
    standard_deviation: 4.09
    group_size: 56
```"
414,3262,3475525,Taste perception,MTL group,choices group,continuous,,98,,98,5.6,1.4,5.3,1.5,0.20597307,0.02051639,,,,,,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
  mean: 5.6
  standard_deviation: 1.4
  group_size: 98
comparator:
  mean: 5.3
  standard_deviation: 1.5
  group_size: 98
```"
71,3043,3321528,handgrip strength,Intensive Care Unit acquired weakness (ICU-AW),without an ICU-AW diagnosis,continuous,,,,,6.6,4.4,23.4,8.9,cannot calculate,cannot calculate,,,,,Does not have group size information in article.,FALSE,6725,3999,TEST,2880,"```yaml
intervention:
    mean: 6.6
    standard_deviation: 4.4
    group_size: x
comparator:
    mean: 23.4
    standard_deviation: 8.9
    group_size: x
```"
580,10217,3504298,Anxious symptoms,Face-based attentional bias modification,Placebo,continuous,,16,,14,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates, and values in figure",FALSE,4963,4205,TEST,3331,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 16
comparator:
    mean: x
    standard_deviation: x
    group_size: 14
```"
658,13177,5773985,duration of surgical procedure,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,32.2,15.5,33.68,18.91,-0.0842565,0.08007099,,,,,Graphic format table,TRUE,2609,2261,TEST,1917,"```yaml
intervention:
  mean: x
  standard_deviation: x
  group_size: 25
comparator:
  mean: x
  standard_deviation: x
  group_size: 25
```"
523,6741,5325897,First test results,Evaluation with feedback,Evaluation without feedback,continuous,,15,,15,10.24,0.77,9.73,0.77,0.64440958,0.1402544,,,,,,TRUE,4260,2410,TEST,1703,"```yaml
intervention:
    mean: 10.24
    standard_deviation: 0.77
    group_size: 15
comparator:
    mean: 9.73
    standard_deviation: 0.77
    group_size: 15
```"
561,9835,3496170,P3a amplitude,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data in figure.,FALSE,2318,1990,TEST,1731,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 15
comparator:
    mean: x
    standard_deviation: x
    group_size: 15
```"
25,3244,2972614,Motion range - Shoulder extension,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,42.66,3.4,42.95,3.98,-0.0781,0.0788,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,"```yaml
intervention:
  mean: 42.66
  standard_deviation: 3.40
  group_size: 30
comparator:
  mean: 42.95
  standard_deviation: 3.98
  group_size: 22
```"
291,6103,4215531,MCCB performance : Visual Learning,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,49.4,12.8,46.5,9.8,0.2491,0.1061,,,,,used post values and Treatment as Usual as Baseline,TRUE,7350,5561,TEST,4156,"```yaml
intervention:
    mean: 47.9
    standard_deviation: 8.8
    group_size: 19
comparator:
    mean: 42.8
    standard_deviation: 12.8
    group_size: 19
```"
505,6485,5419060,Phlebotomy questionnaire score: CDC C,Phlebotomy training programme,Control,continuous,,23,,23,97,3.85,60,5.25,7.89939403,0.76522202,,,,,Back calculated SD using CI,TRUE,9292,5719,TEST,4155,"```yaml
intervention:
    mean: 97
    standard_deviation: x
    group_size: x
comparator:
    mean: 60
    standard_deviation: x
    group_size: x
```"
199,7736,5380284,Rates of POI,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,,FALSE,1731,1429,TEST,1251,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 38
comparator:
    mean: x
    standard_deviation: x
    group_size: 37
```"
532,7829,4230312,improvement of disorder,quetiapine 300 mg/day,placebo,continuous,,283,,204,-15.58,10.43,-11.61,10.12,-0.3847888,0.00858754,,,,,Back calculated SD from SE.,TRUE,6201,5058,TEST,3918,"```yaml
intervention:
    mean: -15.58
    standard_deviation: x
    group_size: 283
comparator:
    mean: -11.61
    standard_deviation: x
    group_size: 204
```"
113,9526,4319071,Vegetable intake,Intervention + targeting environmental-level factors,Individual cognition and self-regulation processes intervention,continuous,,456,,459,167.61,83.71,173.28,81.63,-0.0685,0.0044,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 459
comparator:
    mean: x
    standard_deviation: x
    group_size: 456
```"
367,224,1475568,Minnesota living with heart failure (MLHF) questionnaire baseline scores,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,45,,57,,cannot calculate,cannot calculate,,,,,Only the mean score was given in table.,FALSE,4361,3649,TEST,2573,"```yaml
intervention:
    mean: 45
    standard_deviation: x
    group_size: 59
comparator:
    mean: 57
    standard_deviation: x
    group_size: 64
```"
416,3262,3475525,intent of purchase,MTL group,No label group,continuous,,98,,99,3.8,1.4,4.1,1.5,-0.2059408,0.02041274,,,,,Used values for self.,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
    mean: 3.8
    standard_deviation: 1.4
    group_size: 98
comparator:
    mean: 4.1
    standard_deviation: 1.5
    group_size: 99
```"
357,4711,5884950,chemokines CXCL9,extensively hydrolyzed whey-based formula with short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,extensively hydrolyzed whey-based formula without (control) short-chain galacto-oligosaccharides/long-chain fructo-oligosaccharides (9:1) and Bifidobacterium breve M-16V (active).,continuous,,13,,13,,,,,cannot calculate,cannot calculate,,,,,"mean and std not given, only median and interquartile range",FALSE,11712,6635,TEST,5281,"```yaml
intervention:
  mean: x
  standard_deviation: x
  group_size: 16
comparator:
  mean: x
  standard_deviation: x
  group_size: 15
```"
681,13506,5777419,reduction of plaque,probiotic,placebo,continuous,,16,,15,28.1,14.6,27.4,13,0.0492187,0.12920574,,,,,found in table 2,TRUE,9410,4699,TEST,3181,"```yaml
intervention:
  mean: 28.1
  standard_deviation: 14.6
  group_size: 16
comparator:
  mean: 27.4
  standard_deviation: 13.0
  group_size: 15
```"
525,6742,5325897,Final test results,Evaluation with feedback,Evaluation without feedback,continuous,,15,,15,18.53,0.22,18.99,0.22,-2.0343126,0.20230713,,,,,,TRUE,4260,2410,TEST,1703,"```yaml
intervention:
    mean: 18.53
    standard_deviation: 0.22
    group_size: 15
comparator:
    mean: 18.99
    standard_deviation: 0.22
    group_size: 15
```"
277,6422,3654355,Baseline Height,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,173.2,8.6,172.3,10.4,0.0971,0.0444,,,,,,TRUE,18948,9604,TEST,6664,"```yaml
intervention:
    mean: 173.2
    standard_deviation: 8.6
    group_size: 71
comparator:
    mean: 172.3
    standard_deviation: 10.4
    group_size: 33
```"
176,10753,5086025,Psychological flexibility,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,18.23,8.14,22.46,8.67,-0.4954,0.0793,,,,,Actually psychological inflexibility in the article,TRUE,29049,17627,TEST,13068,"```yaml
intervention:
    mean: -4.23
    standard_deviation: 7.13
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
606,11583,115849,Discontinuation due to lack of efficacy,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 181
comparator:
    mean: x
    standard_deviation: x
    group_size: 357
```"
684,13506,5777419,reduction of plaque,antibiotic,placebo,continuous,,16,,15,31.8,14.8,27.4,13,0.30695109,0.13068633,,,,,found in table 2,TRUE,9410,4699,TEST,3181,"```yaml
intervention:
    mean: 31.8
    standard_deviation: 14.8
    group_size: 16
comparator:
    mean: 27.4
    standard_deviation: 13.0
    group_size: 15
```"
578,8564,2952311,Muscle hardness,Acupressure at local points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,"```yaml
intervention:
    mean: 57.4
    standard_deviation: 4.5
    group_size: 11
comparator:
    mean: 56.9
    standard_deviation: 5.0
    group_size: 11
```"
534,7794,3508963,Pain relief,Intravenous lidocaine,Intravenous morphine,continuous,,120,,120,1.13,1.15,2.23,1.57,-0.7968282,0.01798945,,,,,Values from 30 minutes.,TRUE,3561,2387,TEST,1552,"```yaml
intervention:
  mean: 1.13
  standard_deviation: 1.15
  group_size: 120
comparator:
  mean: 2.23
  standard_deviation: 1.57
  group_size: 120
```"
151,11147,4996097,"n"" consonant improvement",Septoplasty,Control,continuous,,33,,30,11897,,13229,,cannot calculate,cannot calculate,,,,,Used F0 (Hz) values. SD is not given.,FALSE,9291,4535,TEST,2976,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 33
comparator:
    mean: x
    standard_deviation: x
    group_size: 30
```"
393,1120,3577738,effectiveness,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 241
comparator:
    mean: x
    standard_deviation: x
    group_size: 241
```"
117,2983,4323894,Improvement in Glasgow outcome score at 6 months post-trauma,Deep-cooling,No cooling,continuous,,9,,13,,,15.4,,cannot calculate,cannot calculate,,,,,,FALSE,3049,2670,TEST,2328,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 9
comparator:
    mean: x
    standard_deviation: x
    group_size: 13
```"
116,2982,4323894,Improvement in Glasgow outcome score at 6 months post-trauma,Deep-cooling,Mild-cooling,continuous,,9,,10,,,70,,cannot calculate,cannot calculate,,,,,,FALSE,3049,2670,TEST,2328,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 9
comparator:
    mean: x
    standard_deviation: x
    group_size: 10
```"
424,3402,3877023,contrast-to-noise ratios (CNR) of Cervicothoracic Spine - T2w sagittal Cerebrospinal fluid – Vertebral bone,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,18,,21,19.3,10.3,8.2,5.7,1.33530568,0.12603411,,,,,,TRUE,17694,9686,TEST,7100,"```yaml
intervention:
    mean: 19.3
    standard_deviation: 10.3
    group_size: 18
comparator:
    mean: 8.2
    standard_deviation: 5.7
    group_size: 21
```"
605,11583,115849,ACR20 responder criteria,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 181
comparator:
    mean: x
    standard_deviation: x
    group_size: 357
```"
398,2241,4678179,Median overall survival (OS),vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),continuous,,53,,53,6.9,4.09,6.1,5.57,0.1625371,0.03786046,,,,,"Median is given with CI. Since the outcome explicitly says ""median"", including median values. Back calculated SD using CI.",TRUE,9517,6474,TEST,5204,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 53
comparator:
    mean: x
    standard_deviation: x
    group_size: 53
```"
90,5540,3912320,"Correct response rate for 4,000 Hz frequency",Occupational noise,Control,continuous,,19,,10,,,,,cannot calculate,cannot calculate,,,,,Mean were in a figure and SD was not given anywhere.,FALSE,1648,1217,TEST,1015,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 19
comparator:
    mean: x
    standard_deviation: x
    group_size: 10
```"
599,11583,115849,investigator global assessment of disease activity,naproxen 500 mg twice daily,placebo,continuous,,181,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 181
comparator:
    mean: x
    standard_deviation: x
    group_size: 357
```"
207,5501,5380326,Tumor necrosis factor alpha,Vitamin D supplementation,Control,continuous,,40,,40,752.94,1890.16,548.33,1210.9,0.1277,0.0501,,,,,,TRUE,10658,5810,TEST,4260,"```yaml
intervention:
    mean: 752.94
    standard_deviation: 298.86
    group_size: 40
comparator:
    mean: 548.33
    standard_deviation: 191.46
    group_size: 40
```"
70,3041,3321528,ankle dorsiflexion,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,2880,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 24
comparator:
    mean: x
    standard_deviation: x
    group_size: 28
```"
206,5499,5380326,Dipeptidyl peptidase-4,Vitamin D supplementation,Control,continuous,,40,,40,6032.37,1359.15,6408.33,1822.17,-0.2316,0.0503,,,,,Table and text has conflicting numbers. Values are from Table.,TRUE,10658,5810,TEST,4260,"```yaml
intervention:
    mean: 6032.37
    standard_deviation: x
    group_size: 40
comparator:
    mean: 6408.33
    standard_deviation: x
    group_size: 40
```"
275,6420,3654355,Fat mass,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,-15.7,5.3,-0.4,5,-2.9163,0.0853,,,,,,TRUE,18948,9604,TEST,6664,"```yaml
intervention:
    mean: -15.7
    standard_deviation: 5.3
    group_size: 71
comparator:
    mean: -0.4
    standard_deviation: 5.0
    group_size: 33
```"
585,10216,3504298,Depressive symptoms,Word-based attentional bias modification,Placebo,continuous,,16,,15,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates",FALSE,4963,4205,TEST,3331,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 16
comparator:
    mean: x
    standard_deviation: x
    group_size: 15
```"
470,4800,5515881,center of pressure (CoP) sway velocity,demanding balance training program,relaxation group,continuous,,,,,0.63,0.11,0.67,0.18,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,2868,"```yaml
intervention:
  mean: 0.63
  standard_deviation: 0.11
  group_size: 20
comparator:
  mean: 0.67
  standard_deviation: 0.18
  group_size: 20
```"
24,3244,2972614,Motion range - Shoulder flexion,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,168,22.65,174.31,14.98,-0.314,0.0797,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,"```yaml
intervention:
  mean: 168
  standard_deviation: 22.65
  group_size: 30
comparator:
  mean: 174.31
  standard_deviation: 14.98
  group_size: 22
```"
401,2723,5268424,score on the general dimension scale of negative affects (referred to as NA from here onward),view a video featuring individuals that live in extreme poverty,control,continuous,,55,,50,21.036,6.327,17.68,5.859,0.5453569,0.03959808,,,,,,TRUE,12258,6615,TEST,4148,"```yaml
intervention:
    mean: 21.036
    standard_deviation: 6.327
    group_size: 55
comparator:
    mean: 17.680
    standard_deviation: 5.859
    group_size: 50
```"
283,6422,3654355,baseline visceral fat area,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,255.7,64.7,245.6,66.3,0.1538,0.0445,,,,,,TRUE,18948,9604,TEST,6664,"```yaml
intervention:
  mean: 255.7
  standard_deviation: 64.7
  group_size: 71
comparator:
  mean: 245.6
  standard_deviation: 66.3
  group_size: 33
```"
6,11451,1574360,The amount of saturated fat in the foods purchased,fully automated advice that recommended specific switches from selected products higher in saturated fat to alternate similar products lower in saturated fat,control received general non-specific advice about how to eat a diet lower in saturated fat,continuous,,251,,246,0.77,1.37,0.04,0.32,0.7273,0.0086,,,,,Have to use CI to calculate the SDs,TRUE,1959,1620,TEST,1376,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 224
comparator:
    mean: x
    standard_deviation: x
    group_size: 232
```"
423,3402,3877023,contrast-to-noise ratios (CNR) of Thoracolumbar Spine - T2w sagittal Cerebrospinal fluid – Spinal cord,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,30,,34,22.3,13.2,14,5.6,0.8274306,0.06809386,,,,,,TRUE,17694,9686,TEST,7100,"```yaml
intervention:
    mean: 22.3
    standard_deviation: 13.2
    group_size: 30
comparator:
    mean: 14
    standard_deviation: 5.6
    group_size: 34
```"
428,3261,3475525,Scores on the saturated fat quiz,MTL group,No label group,continuous,,98,,99,90.7,20.4,33.6,16.3,3.08231109,0.0444184,,,,,,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
  mean: 90.7
  standard_deviation: 20.4
  group_size: 98
comparator:
  mean: 33.6
  standard_deviation: 16.3
  group_size: 99
```"
149,11146,4996097,"a"" vowel improvement",Septoplasty,Control,continuous,,33,,30,138,,154,,cannot calculate,cannot calculate,,,,,Used F0 (Hz) values. SD is not given.,FALSE,9291,4535,TEST,2976,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 33
comparator:
    mean: x
    standard_deviation: x
    group_size: 30
```"
314,9841,4928400,Operative time,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,74.1,12.2,78,6.4,-0.3985,0.0973,,,,,found in table,TRUE,4037,2288,TEST,1670,"```yaml
intervention:
    mean: 74.1
    standard_deviation: 12.2
    group_size: 22
comparator:
    mean: 78.1
    standard_deviation: 6.4
    group_size: 20
```"
644,12880,5830087,progression-free survival,"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),continuous,,48,,23,,,,,cannot calculate,cannot calculate,,,,,"given as median with confidence interval, cannot calculate",FALSE,11942,10628,TEST,8141,"```yaml
intervention:
    mean: 11.6
    standard_deviation: x
    group_size: 48
comparator:
    mean: 9.6
    standard_deviation: x
    group_size: 23
```"
670,13297,4987981,IL-6 and TNF-α levels,metformin or pioglitazone,placebo,continuous,,37,,23,,,,,cannot calculate,cannot calculate,,,,,Values combined and given in figure,FALSE,9637,7894,TEST,5779,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
673,13314,4550271,treatment according to guidelines,provider,control,continuous,,14,,12,36.4,32,22.6,23,0.47332022,0.15907021,,,,,mean given as percent and std has no unit,TRUE,24886,12978,TEST,8556,"```yaml
intervention:
    mean: 36.4
    standard_deviation: 32
    group_size: 1832
comparator:
    mean: 22.6
    standard_deviation: 23
    group_size: 1536
```"
267,12440,2596788,GERD-knowledge,education,control,continuous,,102,,109,,,,,cannot calculate,cannot calculate,,,,,no standard deviations given or mean differences,FALSE,5143,3554,TEST,2520,"```yaml
intervention:
    mean: 17.1
    standard_deviation: x
    group_size: 102
comparator:
    mean: 14.0
    standard_deviation: x
    group_size: 109
```"
103,1886,4188762,heart rate,remifentanil,ketamine,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 30
comparator:
    mean: x
    standard_deviation: x
    group_size: 30
```"
411,3260,3475525,Correct selection of the healthier product,choices group,TL+SNL group,continuous,,98,,95,72.5,13.2,65.8,7.3,0.62309408,0.02173622,,,,,Available in abstract and table,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
    mean: 72.5
    standard_deviation: 13.2
    group_size: 98
comparator:
    mean: 65.8
    standard_deviation: 7.3
    group_size: 95
```"
162,7712,5056957,BMI reduction at 24 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,560,,425,21.86,6.22,22.06,5.68,-0.0333,0.0041,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,"```yaml
intervention:
    mean: 21.86
    standard_deviation: x
    group_size: 560
comparator:
    mean: 22.06
    standard_deviation: x
    group_size: 425
```"
408,3260,3475525,Correct selection of the healthier product,MTL+caloric intake group,No label group,continuous,,90,,99,73.3,6.9,67.8,10.3,0.61923041,0.02222653,,,,,Available in abstract and table,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
    mean: 73.3
    standard_deviation: 6.9
    group_size: 90
comparator:
    mean: 67.8
    standard_deviation: 10.3
    group_size: 99
```"
529,6915,4411165,effects of cryostimulation on the ANS - heart rate,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,-7.7,2.3,-5.02,1.07,-1.430817,0.25118093,,,,,"Changed from original outcome but adding ""- heart rate"" to make it more specific. Numbers are mean change.",TRUE,3146,2589,TEST,2336,"```yaml
intervention:
  mean: -7.7
  standard_deviation: 2.3
  group_size: 10
comparator:
  mean: -5.02
  standard_deviation: 1.07
  group_size: 10
```"
7,11452,1574360,the average cost of the food,fully automated advice that recommended specific switches from selected products higher in saturated fat to alternate similar products lower in saturated fat,control received general non-specific advice about how to eat a diet lower in saturated fat,continuous,,251,,246,0.63,0.4,0.62,0.36,0.0261,0.008,,,,,Have to use CI to calculate the SDs,TRUE,1959,1620,TEST,1376,"```yaml
intervention:
    mean: 0.63
    standard_deviation: x
    group_size: 224
comparator:
    mean: 0.62
    standard_deviation: x
    group_size: 232
```"
594,11583,115849,Health Assessment Questionnaire disability,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 353
comparator:
    mean: x
    standard_deviation: x
    group_size: 357
```"
147,1273,4880652,"systolic blood pressures at 5, 10, 15, and 20 minutes",fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Means in figure 3's graphics.,FALSE,1406,1149,TEST,966,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 76
comparator:
    mean: x
    standard_deviation: x
    group_size: 70
```"
355,4498,5874317,Horizontal triple jump (non-dominant leg),Bilateral training,Unilateral training,continuous,,9,,9,5.71,0.71,5.7,0.45,0.016,0.2222,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,"```yaml
intervention:
    mean: 6.29
    standard_deviation: 0.31
    group_size: 9
comparator:
    mean: 6.35
    standard_deviation: 0.34
    group_size: 9
```"
612,11584,115849,Health Assessment Questionnaire disability,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 353
comparator:
    mean: x
    standard_deviation: x
    group_size: 181
```"
698,5637,5712123,time to first rescue analgesic,duloxetine 60 and etoricoxib 120mg (group D/E),Placebo group (P),continuous,,30,,30,137,61.3,62,37.2,1.45998637,0.08442967,,,,,found in fig2,TRUE,6401,5359,TEST,3891,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 30
comparator:
    mean: x
    standard_deviation: x
    group_size: 30
```"
648,13097,5976307,induction time,etomidate,propofol based on midazolam,continuous,,62,,62,2.46,0.993,2.21,1,0.24933056,0.03250873,,,,,found in table 2,TRUE,2560,2044,TEST,1751,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 62
comparator:
    mean: x
    standard_deviation: x
    group_size: 62
```"
584,10215,3504298,Depressive symptoms,Face-based attentional bias modification,Placebo,continuous,,16,,14,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates",FALSE,4963,4205,TEST,3331,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 16
comparator:
    mean: x
    standard_deviation: x
    group_size: 14
```"
617,11602,1863515,absolute neutrophil count between 26 and 35 wk,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,-485,,0,,cannot calculate,cannot calculate,,,,,"given as estimated change and no std given, also in figure and graphic format",FALSE,3963,3457,TEST,3103,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 769
comparator:
    mean: x
    standard_deviation: x
    group_size: 667
```"
110,9521,4319071,High-energy snack intake,Individual cognition and self-regulation processes intervention,Control,continuous,,459,,434,2.5,2.79,2.84,2.71,-0.1235,0.0045,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,"```yaml
intervention:
  mean: x
  standard_deviation: x
  group_size: 459
comparator:
  mean: x
  standard_deviation: x
  group_size: 434
```"
12,12632,2667135,number of days with received courses of antibiotics,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,continuous,,103,,97,25.4,,13.5,,cannot calculate,cannot calculate,,,,,SD or CI is missing. Mean is given.,FALSE,11722,8106,TEST,5529,"```yaml
intervention:
    mean: 25.4
    standard_deviation: 12.34
    group_size: 103
comparator:
    mean: 13.5
    standard_deviation: 9.49
    group_size: 97
```"
435,3261,3475525,Scores on sugar quiz,MTL+caloric intake group,choices group,continuous,,90,,98,92.6,15.5,41.9,19.4,2.86225472,0.04310376,,,,,,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
    mean: 92.6
    standard_deviation: 15.5
    group_size: 90
comparator:
    mean: 41.9
    standard_deviation: 19.4
    group_size: 98
```"
212,2913,5459456,lateral bending for the C2-C6 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,9.2,0.9,9.6,1.1,-0.3762,0.2544,,,,,,TRUE,13404,7477,TEST,5693,"```yaml
intervention:
    mean: 14.5
    standard_deviation: 1.3
    group_size: x
comparator:
    mean: 6.5
    standard_deviation: 0.9
    group_size: x
```"
422,3402,3877023,contrast-to-noise ratios (CNR) of Cervicothoracic Spine - T2w sagittal Cerebrospinal fluid – Spinal cord,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,18,,21,18.1,11.6,9.3,5.5,0.97494517,0.11536073,,,,,,TRUE,17694,9686,TEST,7100,"```yaml
intervention:
    mean: 18.1
    standard_deviation: 11.6
    group_size: 18
comparator:
    mean: 9.3
    standard_deviation: 5.5
    group_size: 21
```"
387,1119,3577738,focused on the social presence elements in terms of frequency,website with social presence elements.,website without social presence elements.,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Cannot find the group sizes in the text or table. Also, no numerical values for this outcome is found for each of the conditions.",FALSE,3018,2080,TEST,1653,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
659,13178,5773985,the mean duration of postoperative analgesia,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,508.92,63.3,1840.84,819.51,-2.2556182,0.13087813,,,,,Found in abstract and results,TRUE,2609,2261,TEST,1917,"```yaml
intervention:
    mean: 508.92
    standard_deviation: 63.30
    group_size: 25
comparator:
    mean: 1840.84
    standard_deviation: 819.51
    group_size: 25
```"
319,4723,5539943,reflections of sustain talk,Language Enhanced Attention and Focus MI training condition (MI-LEAF),MI training (MI-AU),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
321,4725,5539943,"Frequency of client ""change talk"" (CT)",Language Enhanced Attention and Focus MI training condition (MI-LEAF),MI training (MI-AU),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,No group sizes and individual means and stds given,FALSE,9850,5076,TEST,3578,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
73,3741,3546023,Urine cotinine levels,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,19,1.179,0.738,0.047,0.017,2.0036,0.1541,,,,,Values are for week 24 (only timepoint after intervention).,TRUE,29733,18035,TEST,11524,"```yaml
intervention:
    mean: 1.179
    standard_deviation: 0.738
    group_size: 20
comparator:
    mean: 0.047
    standard_deviation: 0.017
    group_size: 19
```"
457,4424,4483334,Total weight percentage of calcium,CPP-ACP plus laser (group D),CPP-ACP crème (group C),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,"Original outcome was ""Amount of calcium and phosphate on enamel surface"" but changed to ""Total weight percentage of calcium"" since this seemed more accurate. All numerical values are in a graphical format of table.",FALSE,1396,1236,TEST,1068,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
649,13097,5976307,total procedure time,etomidate,propofol based on midazolam,continuous,,62,,62,29.73,12.23,29.46,16.04,0.01881372,0.03225949,,,,,found in table 2,TRUE,2560,2044,TEST,1751,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 62
comparator:
    mean: x
    standard_deviation: x
    group_size: 62
```"
655,13175,5773985,mean volume of both the solutions used,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,4.15,0.52,4.12,0.6,0.05259525,0.08002766,,,,,Found in abstract and results,TRUE,2609,2261,TEST,1917,"```yaml
intervention:
  mean: 4.15
  standard_deviation: 0.52
  group_size: 25
comparator:
  mean: 4.12
  standard_deviation: 0.60
  group_size: 25
```"
611,11584,115849,Patient global assessment of pain,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 353
comparator:
    mean: x
    standard_deviation: x
    group_size: 181
```"
145,1272,4880652,heart rates,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Means in figure 2's graphics.,FALSE,1406,1149,TEST,966,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 76
comparator:
    mean: x
    standard_deviation: x
    group_size: 70
```"
105,1885,4188762,mean blood pressure,remifentanil,lidocaine,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 30
comparator:
    mean: x
    standard_deviation: x
    group_size: 30
```"
53,5307,3195393,Intermittent restraint,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,5.1,0.07,0.7,0.02,9.6931,0.0498,,,,,Overall intermittent restraint rate for study site.,TRUE,15527,8380,TEST,5589,"```yaml
intervention:
    mean: 5.1
    standard_deviation: 0.07
    group_size: 562
comparator:
    mean: 0.7
    standard_deviation: 0.02
    group_size: 463
```"
95,10163,4173437,Total blood loss,Tranexamic acid,Control,continuous,,30,,30,576,53,823,74,-3.7878,0.1862,,,,,Had to infer that the group sizes were equal.,TRUE,854,745,TEST,637,"```yaml
intervention:
  mean: 576
  standard_deviation: 53
  group_size: 30
comparator:
  mean: 823
  standard_deviation: 74
  group_size: 30
```"
403,2802,5781260,exercise-related loss of muscle strength,lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Mean and CI in figure.,FALSE,4385,3505,TEST,2662,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 20
comparator:
    mean: x
    standard_deviation: x
    group_size: 20
```"
412,3262,3475525,Taste perception,MTL group,No label group,continuous,,98,,99,5.6,1.4,5.8,1.4,-0.1423069,0.02035649,,,,,,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
  mean: 5.6
  standard_deviation: 1.4
  group_size: 98
comparator:
  mean: 5.8
  standard_deviation: 1.4
  group_size: 99
```"
134,2449,4574984,Health-Related Quality of Life at 12 month - females,"intervention group, i.e. patient empowerment through information booklet and diary keeping - females","control group, which received standard care - females",continuous,,110,,95,61.07,30.21,63.27,24.79,-0.0788,0.0196,,,,,Group sizes was inferred using Table of characterisitics. Back calculated SD using CI.,TRUE,12997,7944,TEST,5795,"```yaml
intervention:
    mean: 61.07
    standard_deviation: x
    group_size: x
comparator:
    mean: 63.27
    standard_deviation: x
    group_size: x
```"
575,8562,2952311,Verbal rating scale pain intensity,Acupressure at local points,Control,continuous,,11,,11,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,3603,2475,TEST,2143,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 11
comparator:
    mean: x
    standard_deviation: x
    group_size: 11
```"
660,13179,5773985,number of analgesic tablets,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,1.64,0.99,0.8,1.08,0.7980815,0.08636934,,,,,Graphic format table,TRUE,2609,2261,TEST,1917,"```yaml
intervention:
  mean: 1.64
  standard_deviation: 0.99
  group_size: 25
comparator:
  mean: 0.80
  standard_deviation: 1.08
  group_size: 25
```"
328,5375,5559992,Anxiety,Buprenophine 32 mg,Buprenophine 64 mg,continuous,,5,,4,1,2.23,1.25,2.5,-0.0945,0.4505,,,,,found in table,TRUE,1146,884,TEST,721,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 5
comparator:
    mean: x
    standard_deviation: x
    group_size: 4
```"
450,4005,4879328,weekly moderate physical activity sessions,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,0.19,1.82,-0.68,2.32,0.41353429,0.01877954,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 104
comparator:
    mean: x
    standard_deviation: x
    group_size: 114
```"
352,4495,5874317,Change of direction improvement,Bilateral training,Unilateral training,continuous,,9,,9,5.46,0.2,5.67,0.16,-1.1042,0.2561,,,,,Found in table raw values,TRUE,10785,5696,TEST,4631,"```yaml
intervention:
    mean: 5.46
    standard_deviation: 0.20
    group_size: 9
comparator:
    mean: 5.67
    standard_deviation: 0.16
    group_size: 9
```"
451,4006,4879328,accelerometer-assessed moderate to vigorous physical activity (MVPA),"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,99,,108,7.41,66.12,-16.1,66.25,0.35389959,0.01966279,,,,,Values are from Accelerometer PA in Table 2. Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 104
comparator:
    mean: x
    standard_deviation: x
    group_size: 114
```"
218,2912,5459456,blood loss,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,56,19,51,20,0.2423,0.2518,,,,,,TRUE,13404,7477,TEST,5693,"```yaml
intervention:
    mean: 55.5
    standard_deviation: 18.5
    group_size: x
comparator:
    mean: 51
    standard_deviation: 20
    group_size: x
```"
427,3404,3877023,The mean signal-to-noise (SNR) values,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,44,,49,17.97,6.58,11.28,4.35,1.20253898,0.05091017,,,,,,TRUE,17694,9686,TEST,7100,"```yaml
intervention:
    mean: 17.97
    standard_deviation: 6.58
    group_size: 48
comparator:
    mean: 11.28
    standard_deviation: 4.35
    group_size: 55
```"
671,13313,4550271,Community knowledge,provider,control,continuous,,14,,12,,,,,cannot calculate,cannot calculate,,,,,outcome too broad,FALSE,24886,12978,TEST,8556,"```yaml
intervention:
  mean: x
  standard_deviation: x
  group_size: x
comparator:
  mean: x
  standard_deviation: x
  group_size: x
```"
210,2913,5459456,inflexion-extension for the C4-C5 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,1.4,0.3,1.3,0.2,0.3708,0.2543,,,,,,TRUE,13404,7477,TEST,5693,"```yaml
intervention:
  mean: 1.4
  standard_deviation: 0.3
  group_size: x
comparator:
  mean: 1.3
  standard_deviation: 0.2
  group_size: x
```"
692,5635,5712123,time to first rescue analgesic,duloxetine 60 and etoricoxib 120mg (group D/E),Duloxetine (D),continuous,,30,,30,137,61.3,91.7,35.5,0.89262531,0.0733065,,,,,found in fig2,TRUE,6401,5359,TEST,3891,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 30
comparator:
    mean: x
    standard_deviation: x
    group_size: 30
```"
630,12235,3510731,Median time in seconds (interquartile range) - Protocol link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,continuous,,6051,,5892,3.5,,3.6,,cannot calculate,cannot calculate,,,,,"found in table 1, IQ range given rather and std",FALSE,1665,1296,TEST,943,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 6051
comparator:
    mean: x
    standard_deviation: x
    group_size: 5892
```"
140,1275,4880652,SpO2 at 5 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean in figure 5's graphics.,FALSE,1406,1149,TEST,966,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 76
comparator:
    mean: x
    standard_deviation: x
    group_size: 70
```"
372,226,1475568,Knowledge about heart failure,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,,,,,cannot calculate,cannot calculate,,,,,Only the overall mean difference in score improvement was given.,FALSE,4361,3649,TEST,2573,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 59
comparator:
    mean: x
    standard_deviation: x
    group_size: 64
```"
504,6485,5419060,Phlebotomy questionnaire score: CHC B,Phlebotomy training programme,Control,continuous,,23,,23,93,1.37,58,7.12,6.70952589,0.57627976,,,,,Back calculated SD using CI,TRUE,9292,5719,TEST,4155,"```yaml
intervention:
    mean: 93
    standard_deviation: x
    group_size: x
comparator:
    mean: 58
    standard_deviation: x
    group_size: x
```"
326,5373,5559992,Anxiety,Buprenophine 64 mg,No treatment,continuous,,4,,4,1.25,2.5,26.5,14.7,-2.0802,0.7704,,,,,"decided ""no treatment"" meant baseline",TRUE,1146,884,TEST,721,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 4
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
407,2806,5781260,Interleukin 6,lemon verbena extract,placebo,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Numerical values are not given.,FALSE,4385,3505,TEST,2662,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 20
comparator:
    mean: x
    standard_deviation: x
    group_size: 20
```"
515,6552,4033571,Seizure median percent improvement in North America,Extended-release oxcarbazepine 2400 mg,Control,continuous,,,,,-52.7,,-13.3,,cannot calculate,cannot calculate,,,,,"Group sizes are only in figure, and SD is not available.",FALSE,8206,5593,TEST,4514,"```yaml
intervention:
    mean: -52.7
    standard_deviation: x
    group_size: x
comparator:
    mean: -13.3
    standard_deviation: x
    group_size: x
```"
555,9721,3648394,Flexibility,10-week yoga program,Control,continuous,,18,,19,31,8.7,26.4,10.4,0.46823146,0.11114985,,,,,Numerical values are from Week 11 data for sit and reach test.,TRUE,9556,6245,TEST,4261,"```yaml
intervention:
    mean: 31.0
    standard_deviation: 8.7
    group_size: 17
comparator:
    mean: 26.4
    standard_deviation: 10.4
    group_size: 17
```"
559,9833,3136370,Center for Epidemiologic Studies Depression Scale score,Soy shake,Casein shake (Placebo),continuous,,12,,16,-4,12.35,-8,65.41,0.07716042,0.14593965,,,,,From per protocol,TRUE,6022,3786,TEST,2937,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 25
comparator:
    mean: x
    standard_deviation: x
    group_size: 25
```"
442,8805,4467620,accuracy of the cognitive tasks,Exercise - Hot + Cooling conditions,At rest - Hot + Cooling conditions,continuous,,8,,8,,,,,cannot calculate,cannot calculate,,,,,,FALSE,7288,4607,TEST,3858,"```yaml
intervention:
  mean: x
  standard_deviation: x
  group_size: 8
comparator:
  mean: x
  standard_deviation: x
  group_size: 8
```"
184,4337,5122613,Improvement in faeces consistency,Digestion-resistant maltodextrin,Placebo,continuous,,33,,33,3.4,1,3.2,0.5,0.25,0.0611,,,,,,TRUE,6184,3742,TEST,2832,"```yaml
intervention:
    mean: 3.4
    standard_deviation: 1.0
    group_size: 29
comparator:
    mean: 3.2
    standard_deviation: 0.5
    group_size: 28
```"
74,3742,3546023,serum α1-antitrypsin,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,19,1.75,0.39,1.45,0.24,0.867,0.0936,,,,,Values are for week 24 (only timepoint after intervention).,TRUE,29733,18035,TEST,11524,"```yaml
intervention:
  mean: 1.75
  standard_deviation: 0.39
  group_size: 30
comparator:
  mean: 1.45
  standard_deviation: 0.24
  group_size: 19
```"
221,2914,5459456,Flexion-Extension stiffness of C2-4,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,0.34,0.12,7.47,1.45,-6.5512,1.5912,,,,,"Data is from after fatigue test. Original outcome was just ""The stiffness"".",TRUE,13404,7477,TEST,5693,"```yaml
intervention:
    mean: 0.33
    standard_deviation: 0.11
    group_size: x
comparator:
    mean: 7.20
    standard_deviation: 1.33
    group_size: x
```"
329,5376,5559992,Anxiety,Buprenophine 32 mg,Buprenophine 96 mg,continuous,,5,,5,1,2.23,0,0,0.5725,0.4164,,,,,found in table,TRUE,1146,884,TEST,721,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 5
comparator:
    mean: x
    standard_deviation: x
    group_size: 5
```"
279,6422,3654355,baseline body weight,Intensive lifestyle intervention (ILI) group,Waiting list control,continuous,,71,,33,128.9,19.4,127.1,21.6,0.0888,0.0444,,,,,,TRUE,18948,9604,TEST,6664,"```yaml
intervention:
  mean: 128.9
  standard_deviation: 19.4
  group_size: 71
comparator:
  mean: 127.1
  standard_deviation: 21.6
  group_size: 33
```"
679,13506,5777419,attachment gain,probiotic,placebo,continuous,,16,,15,3.4,0.6,4.3,1.4,-0.8236508,0.14010861,,,,,found in table 2,TRUE,9410,4699,TEST,3181,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 16
comparator:
    mean: x
    standard_deviation: x
    group_size: 15
```"
201,7738,5380284,Pain scores 24 hours and 72 hours after the surgery,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,,FALSE,1731,1429,TEST,1251,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 38
comparator:
    mean: x
    standard_deviation: x
    group_size: 37
```"
69,3041,3321528,knee extension,electrical muscle stimulation (EMS),control,continuous,,24,,28,,,,,cannot calculate,cannot calculate,,,,,Only median and interquartile range is given.,FALSE,6725,3999,TEST,2880,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 24
comparator:
    mean: x
    standard_deviation: x
    group_size: 28
```"
284,6301,3929816,Baseline characteristics and general anesthesia procedure,Intraabdominal pressure 20 mm Hg,Intraabdominal pressure 12 mm Hg,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No quantitative measures given,FALSE,1047,859,TEST,749,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 10
comparator:
    mean: x
    standard_deviation: x
    group_size: 10
```"
531,7830,4230312,improvement of disorder,quetiapine 600 mg/day,placebo,continuous,,289,,204,-14.88,10.54,-11.61,10.12,-0.3148988,0.00846274,,,,,Back calculated SD from SE.,TRUE,6201,5058,TEST,3918,"```yaml
intervention:
    mean: -14.88
    standard_deviation: x
    group_size: 289
comparator:
    mean: -11.61
    standard_deviation: x
    group_size: 204
```"
664,13296,4987981,FPG,metformin,placebo,continuous,,21,,23,101.9,35.1,97.6,20.8,0.14806913,0.09134645,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,"```yaml
intervention:
  mean: 117.1
  standard_deviation: 19.2
  group_size: 21
comparator:
  mean: 99.8
  standard_deviation: 10.0
  group_size: 23
```"
437,3261,3475525,Scores on sodium quiz,MTL+caloric intake group,No label group,continuous,,90,,99,94.1,15.6,42.6,20.7,2.78020714,0.04166067,,,,,,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
    mean: 94.1
    standard_deviation: 15.6
    group_size: 90
comparator:
    mean: 42.6
    standard_deviation: 20.7
    group_size: 99
```"
533,8166,5800236,Months of sick leave,Nacadia® nature-based therapy,Cognitive behavioral therapy,continuous,,37,,35,,,,,cannot calculate,cannot calculate,,,,,Numerical values were not given for this outcome.,FALSE,4517,2571,TEST,1980,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 41
comparator:
    mean: x
    standard_deviation: x
    group_size: 40
```"
699,5638,5712123,time to first rescue analgesic,duloxetine 60 and etoricoxib 120mg (group D/E),etoricoxib (E),continuous,,30,,30,137,61.3,105.3,28.4,0.6549502,0.07024133,,,,,found in fig2,TRUE,6401,5359,TEST,3891,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 30
comparator:
    mean: x
    standard_deviation: x
    group_size: 30
```"
222,2914,5459456,Lateral bending stiffness of C2-4,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,0.05,0.02,2.67,0.68,-5.1485,1.0784,,,,,"Data is from after fatigue test. Original outcome was just ""The stiffness"".",TRUE,13404,7477,TEST,5693,"```yaml
intervention:
    mean: 0.02
    standard_deviation: 0.00
    group_size: x
comparator:
    mean: 2.67
    standard_deviation: 0.68
    group_size: x
```"
596,11583,115849,ACR20 responder criteria,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 353
comparator:
    mean: x
    standard_deviation: x
    group_size: 357
```"
383,949,3278655,maximum total point motion (MTPM),The trabecular metal tibial monoblock component (TM),cemented component.,continuous,,27,,18,0.98,3.91,0.79,2.27,0.0556,0.0926,,,,,Back calculated the SD values from CI. Numerical values are from 5-year follow up.,TRUE,5463,3510,TEST,2857,"```yaml
intervention:
    mean: 0.98
    standard_deviation: x
    group_size: 27
comparator:
    mean: 0.79
    standard_deviation: x
    group_size: 18
```"
591,11583,115849,Tender joint count,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 353
comparator:
    mean: x
    standard_deviation: x
    group_size: 357
```"
694,5636,5712123,postoperative pain on movement,duloxetine 60 and etoricoxib 120mg (group D/E),placebo,continuous,,30,,30,3.5,,3,,cannot calculate,cannot calculate,,,,,values given as score (range),FALSE,6401,5359,TEST,3891,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 30
comparator:
    mean: x
    standard_deviation: x
    group_size: 30
```"
619,11603,1863515,leucocyte count at 35 wk gestation,Zidovudine prophylaxis initiation,placebo,continuous,,754,,656,8818,,8362,,cannot calculate,cannot calculate,,,,,"means given but no std given, tables and figures in graphic format",FALSE,3963,3457,TEST,3103,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 769
comparator:
    mean: x
    standard_deviation: x
    group_size: 667
```"
425,3402,3877023,contrast-to-noise ratios (CNR) of Thoracolumbar Spine - T2w sagittal Cerebrospinal fluid – Vertebral bone,short-bore MR scanner,high-field horizontal open MR scanner,continuous,,30,,34,24,12.9,11.7,6.3,1.22140465,0.07440001,,,,,,TRUE,17694,9686,TEST,7100,"```yaml
intervention:
    mean: 24
    standard_deviation: 12.9
    group_size: 30
comparator:
    mean: 11.7
    standard_deviation: 6.3
    group_size: 34
```"
158,7710,5056957,Weight reduction at 12 months,Multi-component physical activity,Usual PE and sport programmes,continuous,,592,,459,55.91,15.64,56.48,14.76,-0.0373,0.0039,,,,,Back calculated the SD values from CI,TRUE,11185,6045,TEST,4394,"```yaml
intervention:
    mean: 55.91
    standard_deviation: x
    group_size: 592
comparator:
    mean: 56.48
    standard_deviation: x
    group_size: 459
```"
593,11583,115849,Patient global assessment of pain,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 353
comparator:
    mean: x
    standard_deviation: x
    group_size: 357
```"
463,4431,5726464,Lipid profile: HDL-c,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 79
comparator:
    mean: x
    standard_deviation: x
    group_size: 86
```"
77,3746,3546023,The percentage of NK cells,200 mg/day palmvitee smokers,200 mg/day palmvitee nonsmokers,continuous,,30,,29,19.03,7.82,24.72,8.78,-0.6721,0.0716,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"```yaml
intervention:
  mean: 19.03
  standard_deviation: 7.82
  group_size: 30
comparator:
  mean: 24.72
  standard_deviation: 8.78
  group_size: 29
```"
506,6485,5419060,Phlebotomy questionnaire score: CDC D,Phlebotomy training programme,Control,continuous,,23,,23,97,1.21,63,4.31,10.5566479,1.29829148,,,,,Back calculated SD using CI,TRUE,9292,5719,TEST,4155,"```yaml
intervention:
    mean: 97
    standard_deviation: 0.495
    group_size: 23
comparator:
    mean: 63
    standard_deviation: 1.732
    group_size: 23
```"
530,6917,4411165,Tskin of the head,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,Numerical values are only in the figures.,FALSE,3146,2589,TEST,2336,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 10
comparator:
    mean: x
    standard_deviation: x
    group_size: 10
```"
667,13296,4987981,total cholesterol,pioglitazone,placebo,continuous,,16,,23,207.2,42.3,184.4,37.5,0.5651889,0.11007363,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,"```yaml
intervention:
    mean: 24.0
    standard_deviation: 29.5
    group_size: 16
comparator:
    mean: 1.4
    standard_deviation: 29.2
    group_size: 23
```"
220,2912,5459456,time before eating,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,4.5,2.2,3.9,2.3,0.6791,0.2644,,,,,,TRUE,13404,7477,TEST,5693,"```yaml
intervention:
    mean: 4.5
    standard_deviation: 2.0
    group_size: x
comparator:
    mean: 3.9
    standard_deviation: 2.3
    group_size: x
```"
524,6741,5325897,Second test results,Evaluation with feedback,Evaluation without feedback,continuous,,15,,15,17.73,0.46,12.13,0.47,11.7163546,2.42121609,,,,,,TRUE,4260,2410,TEST,1703,"```yaml
intervention:
    mean: 17.73
    standard_deviation: 0.46
    group_size: 15
comparator:
    mean: 12.13
    standard_deviation: 0.47
    group_size: 15
```"
183,4341,5122613,Baseline characteristics and diet,Digestion-resistant maltodextrin,Placebo,continuous,,33,,33,10,4.6,11.5,4.6,-0.3222,0.0614,,,,,Mean daily fiber intake,TRUE,6184,3742,TEST,2832,"```yaml
intervention:
  mean: 10.0
  standard_deviation: 4.6
  group_size: 33
comparator:
  mean: 11.5
  standard_deviation: 4.6
  group_size: 33
```"
301,5600,4355974,Days patient had to slow down,BostonBreathes system,Control,continuous,,28,,14,-1.4,,-0.4,,cannot calculate,cannot calculate,,,,,"standard deviations not given, means are mean change",FALSE,7450,5464,TEST,3820,"```yaml
intervention:
    mean: -1.4
    standard_deviation: x
    group_size: 28
comparator:
    mean: -0.4
    standard_deviation: x
    group_size: 14
```"
311,7834,4541185,drop in heart rate,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,76.1,8.91,76.77,8.76,-0.0748,0.0667,,,,,found in table,TRUE,1359,1043,TEST,907,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 30
comparator:
    mean: x
    standard_deviation: x
    group_size: 30
```"
150,11145,4996097,Total nasal resistance,Septoplasty,Control,continuous,,33,,30,0.25,,0.27,,cannot calculate,cannot calculate,,,,,Used preoperative values. SD is not given.,FALSE,9291,4535,TEST,2976,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 33
comparator:
    mean: 0.27
    standard_deviation: x
    group_size: 30
```"
308,7832,4541185,duration of analgesia,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,878.33,89.955,613.1,51.797,2.7597,0.1301,,,,,found in text,TRUE,1359,1043,TEST,907,"```yaml
intervention:
    mean: 878.33
    standard_deviation: 89.955
    group_size: 30
comparator:
    mean: 613.10
    standard_deviation: 51.797
    group_size: 30
```"
488,6383,3786549,Baseline characteristics: height,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,154.86,5.45,153.43,5.88,0.25003828,0.04580977,,,,,,TRUE,9725,6231,TEST,4323,"```yaml
intervention:
  mean: 154.86
  standard_deviation: 5.45
  group_size: 44
comparator:
  mean: 153.43
  standard_devization: 5.88
  group_size: 44
```"
368,216,1475568,Heart failure-related quality of life at the end of treatment,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,1,,5,,cannot calculate,cannot calculate,,,,,Only the mean change was found in text.,FALSE,4361,3649,TEST,2573,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 59
comparator:
    mean: x
    standard_deviation: x
    group_size: 64
```"
647,13025,4675066,The mean motor score on the Bayley-III,iodine (150 μg/d),placebo,continuous,,27,,26,93.9,10.8,92.4,9.7,0.14381908,0.07569371,,,,,found in table 2,TRUE,6682,5735,TEST,4224,"```yaml
intervention:
    mean: 93.9
    standard_deviation: 10.8
    group_size: 27
comparator:
    mean: 92.4
    standard_deviation: 9.7
    group_size: 26
```"
638,12721,4132222,"higher prevalence of lesion scabbing, a sign of healing",application of a canola phenolic acid-based cream (CPA),placebo,continuous,,30,,15,,,,,cannot calculate,cannot calculate,,,,,no raw values given and can only be estimated from figure,FALSE,2177,1885,TEST,1617,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 30
comparator:
    mean: x
    standard_deviation: x
    group_size: 15
```"
100,930,4183415,Completed treatment,receive text message reminders about what advice to provide when dispensing artemether-lumefantrine (AL).,no text message,continuous,,40,,37,68.3,23.4,69.8,20.9,-0.0668,0.0521,,,,,Data found in Table 6.,TRUE,10420,7106,TEST,5310,"```yaml
intervention:
    mean: 68.3
    standard_deviation: 23.4
    group_size: 453
comparator:
    mean: 69.8
    standard_deviation: 20.9
    group_size: 451
```"
675,13315,4550271,the proportion of patients who tested positive and received (or were prescribed) an ACT,provider,control,continuous,,14,,12,56.1,31,64.2,28,-0.2644318,0.1561066,,,,,mean given as percent and std has no unit,TRUE,24886,12978,TEST,8556,"```yaml
intervention:
    mean: 56.1
    standard_deviation: 31
    group_size: 142
comparator:
    mean: 64.2
    standard_deviation: 28
    group_size: 320
```"
614,11584,115849,ACR20 responder criteria,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 353
comparator:
    mean: x
    standard_deviation: x
    group_size: 181
```"
247,10308,5571493,QT interval,Saline + Quinine infusion,Saline without Quinine infusion,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No numerical values are given.,FALSE,1507,1019,TEST,928,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 10
comparator:
    mean: x
    standard_deviation: x
    group_size: 10
```"
590,11583,115849,investigator global assessment of disease activity,etoricoxib 90 mg once daily,placebo,continuous,,353,,357,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 353
comparator:
    mean: x
    standard_deviation: x
    group_size: 357
```"
200,7737,5380284,Consumption of fentanyl,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,,FALSE,1731,1429,TEST,1251,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 38
comparator:
    mean: x
    standard_deviation: x
    group_size: 37
```"
519,6700,5154016,Second 24 h drainage volume,Collagen hemostatic sponge,Gelatin sponge,continuous,,30,,30,63.3,8.9,63.5,14.2,-0.0166581,0.06666898,,,,,,TRUE,3046,2156,TEST,1642,"```yaml
intervention:
    mean: 63.3
    standard_deviation: 8.9
    group_size: 30
comparator:
    mean: 63.5
    standard_deviation: 14.2
    group_size: 32
```"
52,5306,3195393,Restraint frecuency,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,13.6,0.07,11.5,0.13,20.6573,0.2121,,,,,Added intermittent and continuous numbers from study site,TRUE,15527,8380,TEST,5589,"```yaml
intervention:
  mean: x
  standard_deviation: x
  group_size: 562
comparator:
  mean: x
  standard_deviation: x
  group_size: 463
```"
76,3744,3546023,The percentage of B cells,200 mg/day palmvitee smokers,baseline,continuous,,30,,30,14.06,3.81,14.4,4.03,-0.0856,0.0667,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"```yaml
intervention:
  mean: 14.40
  standard_deviation: 4.03
  group_size: 30
comparator:
  mean: 15.54
  standard_deviation: 5.06
  group_size: 28
```"
552,9725,3648394,Quality of life - PCS (SF36),10-week yoga program,Control,continuous,,18,,19,47.5,2.7,46.9,4.8,0.1496389,0.10848973,,,,,"Original outcome was just ""Quality of Life"". Numerical values are from Week 11.",TRUE,9556,6245,TEST,4261,"```yaml
intervention:
    mean: 47.5
    standard_deviation: 2.7
    group_size: 18
comparator:
    mean: 46.9
    standard_deviation: 4.8
    group_size: 19
```"
170,2795,5079604,Cox proportional hazards of failure-free survival,"metformin 1,000 mg daily",sitagliptin 100 mg daily,continuous,,17,,16,,,,,cannot calculate,cannot calculate,,,,,Data is in figure.,FALSE,12690,6902,TEST,4923,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 17
comparator:
    mean: x
    standard_deviation: x
    group_size: 16
```"
447,4003,4879328,effects for walking,"Get Healthy, Stay Healthy' (GHSH)",no continued contact,continuous,,104,,114,-0.55,2.29,0.31,3.84,-0.2681458,0.01855223,,,,,Back calculated SD using CI.,TRUE,12872,8442,TEST,5640,"```yaml
intervention:
    mean: -0.55
    standard_deviation: x
    group_size: 104
comparator:
    mean: 0.31
    standard_deviation: x
    group_size: 114
```"
307,7831,4541185,duration of motor block,ropivacaine + diluted clonidine with saline,ropivacaine + saline,continuous,,30,,30,621.67,46.76,500.86,44.58,2.6102,0.1234,,,,,found in text,TRUE,1359,1043,TEST,907,"```yaml
intervention:
    mean: 621.67
    standard_deviation: 46.76
    group_size: 30
comparator:
    mean: 500.86
    standard_deviation: 44.58
    group_size: 30
```"
469,4799,5515881,dynamic balance performance on the stability platform,demanding balance training program,relaxation group,continuous,,,,,7.54,2.57,6.29,1.84,cannot calculate,cannot calculate,,,,,Group sizes are in methods section only. Numerical values are from posttest.,FALSE,4475,3500,TEST,2868,"```yaml
intervention:
  mean: 7.54
  standard_deviation: 2.57
  group_size: x
comparator:
  mean: 6.29
  standard_deviation: 1.84
  group_size: x
```"
483,5712,3343759,Amsterdam-Nijmegen everyday language test (ANELT),very early speech and language therapy (SLT),control,continuous,,59,,55,,,,,cannot calculate,cannot calculate,,,,,"Median values are reported. Group size is based on ANELT by day 21, intent-to-treat.",FALSE,3838,2633,TEST,2065,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 59
comparator:
    mean: x
    standard_deviation: x
    group_size: 55
```"
249,10310,5571493,Hypoglycemia,Saline + Quinine infusion,Saline without Quinine infusion,continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,No numerical values are given.,FALSE,1507,1019,TEST,928,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 10
comparator:
    mean: x
    standard_deviation: x
    group_size: 10
```"
434,3261,3475525,Scores on sugar quiz,MTL group,choices group,continuous,,98,,98,90,20.7,41.9,19.4,2.38845924,0.03496107,,,,,,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
    mean: 90.0
    standard_deviation: 20.7
    group_size: 98
comparator:
    mean: 41.9
    standard_deviation: 19.4
    group_size: 98
```"
81,3740,3546023,tocotrienol levels,200 mg/day palmvitee nonsmokers,baseline,continuous,,29,,29,675.16,150,63.6,5.67,5.6842,0.3475,,,,,Values are between baseline and week 24 (final timepoint).,TRUE,29733,18035,TEST,11524,"```yaml
intervention:
    mean: 675.16
    standard_deviation: 150.00
    group_size: 29
comparator:
    mean: 62.49
    standard_deviation: 6.69
    group_size: 27
```"
317,9844,4928400,Hospital stay,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,4.2,1.2,2.1,1.1,1.7938,0.1338,,,,,,TRUE,4037,2288,TEST,1670,"```yaml
intervention:
    mean: 4.2
    standard_deviation: 1.2
    group_size: 22
comparator:
    mean: 2.1
    standard_deviation: 1.1
    group_size: 20
```"
115,9524,4319071,Fruit intake,Intervention + targeting environmental-level factors,Individual cognition and self-regulation processes intervention,continuous,,456,,459,2.17,1.71,2.14,1.71,0.0175,0.0044,,,,,Values are from 4-month follow up (final timepoint). Back calculated the SD values from SE.,TRUE,26475,16822,TEST,9628,"```yaml
intervention:
  mean: x
  standard_deviation: x
  group_size: 459
comparator:
  mean: x
  standard_deviation: x
  group_size: 456
```"
426,3403,3877023,Scanning times,high-field horizontal open MR scanner,short-bore MR scanner,continuous,,49,,44,32,22,20,9,0.69457406,0.04572916,,,,,,TRUE,17694,9686,TEST,7100,"```yaml
intervention:
    mean: 31.7
    standard_deviation: 21.6
    group_size: 55
comparator:
    mean: 19.8
    standard_deviation: 8.5
    group_size: 48
```"
374,227,1475568,Self-efficacy,Follow-up and thorough education on self-care,Standard information about self-care,continuous,,59,,64,,,,,cannot calculate,cannot calculate,,,,,Only the overall mean difference in score improvement was given.,FALSE,4361,3649,TEST,2573,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 59
comparator:
    mean: x
    standard_deviation: x
    group_size: 64
```"
565,9839,3496170,N1 amplitude,Biperiden,Placebo,continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,Group sizes are not available and numerical data is not given.,FALSE,2318,1990,TEST,1731,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 15
comparator:
    mean: x
    standard_deviation: x
    group_size: 15
```"
51,5308,3195393,Continuous restraint,After restraint reduction program,Before restraint reduction program,continuous,,562,,463,8.5,0.07,10.8,0.13,-19.6737,0.1927,,,,,Overall continuous restraint rate for study site.,TRUE,15527,8380,TEST,5589,"```yaml
intervention:
  mean: 8.5
  standard_deviation: 0.07
  group_size: 562
comparator:
  mean: 10.8
  standard_deviation: 0.13
  group_size: 463
```"
608,11584,115849,investigator global assessment of disease activity,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 353
comparator:
    mean: x
    standard_deviation: x
    group_size: 181
```"
219,2912,5459456,recovery time,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,anterior cervical corpectomy and fusion (ACCF),continuous,,8,,8,4.1,2,3.5,1.4,0.3286,0.2534,,,,,,TRUE,13404,7477,TEST,5693,"```yaml
intervention:
    mean: 3.85
    standard_deviation: 1.85
    group_size: x
comparator:
    mean: 3.5
    standard_deviation: 1.4
    group_size: x
```"
461,4430,5726464,25(OH)D levels,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 79
comparator:
    mean: x
    standard_deviation: x
    group_size: 86
```"
294,6104,4215531,MCCB performance : Reasoning,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,47.9,8.8,46.5,9.8,0.1472,0.1055,,,,,used post values and Treatment as Usual as Baseline,TRUE,7353,5561,TEST,4156,"```yaml
intervention:
    mean: 39.3
    standard_deviation: 10.4
    group_size: 19
comparator:
    mean: 44.5
    standard_deviation: 10.7
    group_size: 19
```"
303,3879,4357072,reduction in burning sensation,topical pimecrolimus cream 1%,triamcinolone acetonide oral paste 0.1%,continuous,,15,,15,1,2.1,5.3,6.1,-0.9171,0.1474,,,,,significance found in abstract and numbers in results,TRUE,2097,1624,TEST,1385,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 15
comparator:
    mean: x
    standard_deviation: x
    group_size: 15
```"
98,931,4183415,completion of each dose at the correct time,receive text message reminders about what advice to provide when dispensing artemether-lumefantrine (AL).,no text message,continuous,,40,,37,33.1,21.6,32.6,18.4,0.0246,0.052,,,,,Data found in Table 6.,TRUE,10420,7106,TEST,5310,"```yaml
intervention:
    mean: 33.1
    standard_deviation: 21.6
    group_size: 453
comparator:
    mean: 32.6
    standard_deviation: 18.4
    group_size: 451
```"
318,9845,4928400,Time for return to daily activities,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,continuous,,22,,20,13.3,1.7,9,1.6,2.5595,0.1734,,,,,,TRUE,4037,2288,TEST,1670,"```yaml
intervention:
    mean: 13.3
    standard_deviation: 1.7
    group_size: 22
comparator:
    mean: 9.0
    standard_deviation: 1.6
    group_size: 20
```"
677,13505,5777419,the total cultivable microbiota,probiotic,placebo,continuous,,16,,15,,,,,cannot calculate,cannot calculate,,,,,median and IQ scores given,FALSE,9410,4699,TEST,3181,"```yaml
intervention:
  mean: x
  standard_deviation: x
  group_size: 16
comparator:
  mean: x
  standard_deviation: x
  group_size: 15
```"
687,13762,2836833,weight loss,1500 mg calcium,500 mg calcium,continuous,,17,,17,,,,,cannot calculate,cannot calculate,,,,,"assumed group sizes were half and half of 34, values for low and high calcium groups have multiple seperated groups within them",FALSE,12992,7163,TEST,5694,"```yaml
intervention:
    mean: 8.5
    standard_deviation: 2.7
    group_size: x
comparator:
    mean: 7.2
    standard_deviation: 2.8
    group_size: x
```"
290,6103,4215531,MCCB performance : Attentional Vigilance,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,38.5,11.8,41.3,10.1,-0.2496,0.1061,,,,,used post values and Treatment as Usual as Baseline,TRUE,7350,5561,TEST,4156,"```yaml
intervention:
  mean: 38.5
  standard_deviation: 11.8
  group_size: 19
comparator:
  mean: 33.6
  standard_deviation: 11.5
  group_size: 19
```"
583,10218,3504298,Difference of cortisol on waking and the highest level of following samples,Word-based attentional bias modification,Placebo,continuous,,16,,15,,,,,cannot calculate,cannot calculate,,,,,"F-values given, cant use for point estimates, and values in figure",FALSE,4963,4205,TEST,3331,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 16
comparator:
    mean: x
    standard_deviation: x
    group_size: 15
```"
193,2094,5360580,Plasma PlsPE,1 mg/day of Pls purified from scallop,placebo,continuous,,138,,131,-0.59,1.11,-0.63,1.08,0.0364,0.0149,,,,,Data is from after 28 weeks (final timepoint). Back calculated the SD values using CI values.,TRUE,11096,9099,TEST,6033,"```yaml
intervention:
    mean: -0.59
    standard_deviation: x
    group_size: 138
comparator:
    mean: -0.63
    standard_deviation: x
    group_size: 131
```"
146,1272,4880652,visual analogue scores,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean and SD are in table that is in graphic form.,FALSE,1406,1149,TEST,966,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 76
comparator:
    mean: x
    standard_deviation: x
    group_size: 70
```"
661,13216,4458006,amplitude of whisking,facial nerve transection and subsequent repair either at the main trunk of the nerve (group 1),"2 cm distally, at the main bifurcation (group 2)",continuous,,12,,12,17.2,,6.9,,cannot calculate,cannot calculate,,,,,No std given,FALSE,1302,1180,TEST,1009,"```yaml
intervention:
    mean: 17.2
    standard_deviation: x
    group_size: 12
comparator:
    mean: 5.9
    standard_deviation: x
    group_size: 12
```"
292,6104,4215531,MCCB performance : Working Memory,facial affect training (FAT) in 20 daily 1-hour sessions,baseline,continuous,,19,,19,48.2,9.2,50.8,12.1,-0.2368,0.106,,,,,used post values and Treatment as Usual as Baseline,TRUE,7351,5561,TEST,4156,"```yaml
intervention:
    mean: 48.2
    standard_deviation: 9.2
    group_size: 19
comparator:
    mean: 44.6
    standard_deviation: 10.2
    group_size: 19
```"
680,13506,5777419,reduction of PPD,probiotic,placebo,continuous,,16,,15,2.2,0.3,2.5,0.6,-0.6224049,0.13541486,,,,,found in table 2,TRUE,9410,4699,TEST,3181,"```yaml
intervention:
  mean: 2.2
  standard_deviation: 0.3
  group_size: 16
comparator:
  mean: 2.5
  standard_deviation: 0.6
  group_size: 15
```"
549,8464,3263860,PAID questionnaire fear of hypoglycemia,Real-Time Continuous Glucose Monitoring,Control,continuous,,69,,68,,,,,cannot calculate,cannot calculate,,,,,Numerical values in Table which is a graphic,FALSE,3178,2587,TEST,2232,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 69
comparator:
    mean: x
    standard_deviation: x
    group_size: 68
```"
148,1274,4880652,Diastolic blood pressures at 5 minutes,fentanyl (1 µg/kg) and propofol,paracetamol (20 mg/kg) and propofol,continuous,,76,,70,,,,,cannot calculate,cannot calculate,,,,,Mean in figure 4's graphics.,FALSE,1406,1149,TEST,966,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 76
comparator:
    mean: x
    standard_deviation: x
    group_size: 70
```"
607,11584,115849,Patient global assessment of disease activity,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: 66
    standard_deviation: 20
    group_size: 353
comparator:
    mean: 65
    standard_deviation: 19
    group_size: 181
```"
581,11584,115849,Discontinuation due to lack of efficacy,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 353
comparator:
    mean: x
    standard_deviation: x
    group_size: 181
```"
9,9684,2363753,Hospital stay,Amifostine,Control,continuous,,20,,20,,,,,cannot calculate,cannot calculate,,,,,Only abstract is available. Full text in PDF only.,FALSE,887,780,TEST,725,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
657,13176,5773985,objective onset of action,0.5% bupivacaine with 1:200000 epinephrine in group I,mixture of 39 ml of 0.5% bupivacaine with epinephrine 1:200000 and 1 ml of 300 _g buprenorphine (3 _g/kg)in group II,continuous,,25,,25,7.4,1.93,7.28,1.59,0.06679907,0.08004462,,,,,Found in abstract and results,TRUE,2609,2261,TEST,1917,"```yaml
intervention:
    mean: 7.28
    standard_deviation: 1.59
    group_size: 25
comparator:
    mean: 7.40
    standard_deviation: 1.93
    group_size: 25
```"
609,11584,115849,Tender joint count,etoricoxib 90 mg once daily,naproxen 500 mg twice daily,continuous,,353,,181,,,,,cannot calculate,cannot calculate,,,,,"found in table 2, but differences given rather than raw values. Also ranges provided rather than STD, cannot calculate",FALSE,6464,5362,TEST,4091,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 353
comparator:
    mean: x
    standard_deviation: x
    group_size: 181
```"
241,8053,5534041,overall working memory (WM) performance in autism spectrum disorder (ASD),right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),left dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),continuous,,12,,12,6,0.9,6.2,1.8,-0.1357,0.1671,,,,,,TRUE,6951,5679,TEST,4357,"```yaml
intervention:
    mean: 0.11
    standard_deviation: 0.81
    group_size: 12
comparator:
    mean: 0.13
    standard_deviation: 0.82
    group_size: 12
```"
453,4432,5726464,Glucose,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 79
comparator:
    mean: x
    standard_deviation: x
    group_size: 86
```"
365,12886,5976949,leptin/adiponectin ratio (LAR),"GDM2 (less tight glycaemic targets, <5.3 mmol/L and < 7.8 mmol/L)","GDM1 (tight glycaemic targets, fasting blood glucose_<_5.1_mmol/L and <7.0_mmol/L postprandial) postprandial,), control group- normal glucose tolerance",continuous,,21,,45,1.7,1.66,,,cannot calculate,cannot calculate,,,,,combined means and stds not given,FALSE,4402,2905,TEST,2274,"```yaml
intervention:
  mean: 1.70
  standard_deviation: 1.66
  group_size: 21
comparator:
  mean: 0.97
  standard_deviation: 1.31
  group_size: 20
```"
196,2097,5360580,WMS-R (0 min),1 mg/day of Pls purified from scallop,placebo,continuous,,24,,24,1.29,3.14,1.08,1.55,0.0834,0.0834,,,,,Data is from 28 weeks (final timepoint). Back calculated the SD values using CI values.,TRUE,11096,9099,TEST,6033,"```yaml
intervention:
    mean: 1.41
    standard_deviation: x
    group_size: 140
comparator:
    mean: 1.39
    standard_deviation: x
    group_size: 135
```"
347,10234,5686687,Need for Ibuprofen,Resveratrol,Placebo,continuous,,22,,22,1200,848,5640,328,-6.7818,0.6136,,,,,found in table,TRUE,7451,3515,TEST,2366,"```yaml
intervention:
    mean: 1200
    standard_deviation: 848
    group_size: 5
comparator:
    mean: 5640
    standard_deviation: 328
    group_size: 5
```"
683,13506,5777419,reduction of PPD,antibiotic,placebo,continuous,,16,,15,2.3,0.3,2.5,0.6,-0.4149366,0.13194364,,,,,found in table 2,TRUE,9410,4699,TEST,3181,"```yaml
intervention:
    mean: 2.3
    standard_deviation: 0.3
    group_size: 16
comparator:
    mean: 2.5
    standard_deviation: 0.6
    group_size: 15
```"
551,9724,3648394,Push-up test,10-week yoga program,Control,continuous,,18,,19,21,11,20,13,0.08105953,0.10827593,,,,,Numerical values are from Week 11.,TRUE,9556,6245,TEST,4261,"```yaml
intervention:
    mean: 21
    standard_deviation: 11
    group_size: 18
comparator:
    mean: 20
    standard_deviation: 13
    group_size: 19
```"
511,6550,4033571,Overall seizure median percent improvement,Extended-release oxcarbazepine 2400 mg,Control,continuous,,111,,117,-42.9,,-28.7,,cannot calculate,cannot calculate,,,,,SD was not given,FALSE,8206,5593,TEST,4514,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 123
comparator:
    mean: x
    standard_deviation: x
    group_size: 121
```"
558,9831,3136370,Center for Epidemiologic Studies Depression Scale score,Soy shake,Control,continuous,,12,,16,-4,12.35,-8,65.41,0.07716042,0.14593965,,,,,From per protocol,TRUE,6022,3786,TEST,2937,"```yaml
intervention:
  mean: x
  standard_deviation: x
  group_size: 25
comparator:
  mean: x
  standard_deviation: x
  group_size: 25
```"
175,10752,5086025,Intuitive eating total score,Intuitive Eating and Acceptance and Commitment Therapy,Control,continuous,,26,,26,3.45,0.55,2.54,0.58,1.5858,0.1011,,,,,Actually comparing preintervention and postintervention,TRUE,29049,17627,TEST,13068,"```yaml
intervention:
    mean: 3.45
    standard_deviation: 0.55
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
439,3261,3475525,Scores on sodium quiz,MTL+caloric intake group,choices group,continuous,,90,,98,94.1,15.6,47.1,21.1,2.50703599,0.03803123,,,,,,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
    mean: 94.1
    standard_deviation: 15.6
    group_size: 90
comparator:
    mean: 47.1
    standard_deviation: 21.1
    group_size: 98
```"
28,3244,2972614,Motion range - Shoulder internal rotation,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,49.33,9.62,49.77,4.49,-0.055,0.0788,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,"```yaml
intervention:
  mean: 49.33
  standard_deviation: 9.62
  group_size: 30
comparator:
  mean: 49.77
  standard_deviation: 4.49
  group_size: 22
```"
460,4425,4483334,Total weight percentage of phosphate,CPP-ACP plus laser (group D),CPP-ACP crème (group C),continuous,,,,,,,,,cannot calculate,cannot calculate,,,,,All numerical values are in a graphical format of table.,FALSE,1396,1236,TEST,1068,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: x
comparator:
    mean: x
    standard_deviation: x
    group_size: x
```"
410,3260,3475525,Correct selection of the healthier product,choices group,No label group,continuous,,98,,99,72.5,13.2,67.8,10.3,0.3957062,0.02070251,,,,,Available in abstract and table,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
    mean: 72.5
    standard_deviation: 13.2
    group_size: 98
comparator:
    mean: 67.8
    standard_deviation: 10.3
    group_size: 99
```"
203,5496,5380326,Vitamin D levels,Vitamin D supplementation,Control,continuous,,40,,40,45.93,15.37,21.87,5.31,2.0722,0.0768,,,,,,TRUE,10658,5810,TEST,4260,"```yaml
intervention:
    mean: 45.93
    standard_deviation: x
    group_size: 40
comparator:
    mean: 21.87
    standard_deviation: x
    group_size: 40
```"
195,2096,5360580,"WMS-R (30 min) In the patients aged 77 years or younger,",1 mg/day of Pls purified from scallop,placebo,continuous,,19,,21,1.84,3.87,0,0.96,0.6551,0.1056,,,,,Data is from 24 weeks (final timepoint). Back calculated the SD values using CI values.,TRUE,11096,9099,TEST,6033,"```yaml
intervention:
    mean: 1.84
    standard_deviation: x
    group_size: 19
comparator:
    mean: 0.00
    standard_deviation: x
    group_size: 21
```"
96,10165,4173437,Coagulation profile,Tranexamic acid,Control,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,Had to infer that the group sizes were equal. Data is in table in graphic format.,FALSE,854,745,TEST,637,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 30
comparator:
    mean: x
    standard_deviation: x
    group_size: 30
```"
30,5576,3003523,Short-Form 36-Items improvement,Certolizumab 200 mg,Control,continuous,,393,,199,38.1,9.5,31.5,7.4,0.7447,0.008,,,,,Used values for PCS after 52 weeks (final timepoint).,TRUE,12247,10091,TEST,7520,"```yaml
intervention:
  mean: 5.6
  standard_deviation: 0.7
  group_size: 393
comparator:
  mean: 2.0
  standard_deviation: 0.8
  group_size: 199
```"
31,5577,3003523,Short-Form 36-Items improvement,Certolizumab 400 mg,Control,continuous,,390,,199,38.9,8.9,31.5,7.4,0.8773,0.0082,,,,,Used values for PCS after 52 weeks (final timepoint).,TRUE,12247,10091,TEST,7520,"```yaml
intervention:
  mean: 6.4
  standard_deviation: x
  group_size: 390
comparator:
  mean: 2.1
  standard_deviation: x
  group_size: 199
```"
349,10236,5686687,CA-125 levels,Resveratrol,Placebo,continuous,,22,,22,,,,,cannot calculate,cannot calculate,,,,,median and ranges given,FALSE,7451,3515,TEST,2366,"```yaml
intervention:
  mean: ""x""
  standard_deviation: ""x""
  group_size: 22
comparator:
  mean: ""x""
  standard_deviation: ""x""
  group_size: 22
```"
454,4432,5726464,insulin,Vitamin D plus calcium supplementation,Placebo,continuous,,79,,86,,,,,cannot calculate,cannot calculate,,,,,Median was reported.,FALSE,6563,4244,TEST,3133,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 79
comparator:
    mean: x
    standard_deviation: x
    group_size: 86
```"
91,5539,3912320,"Correct response rate for 2,000 Hz frequency",Occupational noise,Control,continuous,,19,,10,,,,,cannot calculate,cannot calculate,,,,,Mean were in a figure and SD was not given anywhere.,FALSE,1648,1217,TEST,1015,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 19
comparator:
    mean: x
    standard_deviation: x
    group_size: 10
```"
431,3261,3475525,Scores on the saturated fat quiz,MTL+caloric intake group,choices group,continuous,,90,,98,92.3,15.1,35.7,15.9,3.63162908,0.0563916,,,,,,TRUE,9086,4934,TEST,3542,"```yaml
intervention:
    mean: 92.3
    standard_deviation: 15.1
    group_size: 90
comparator:
    mean: 35.7
    standard_deviation: 15.9
    group_size: 98
```  "
668,13296,4987981,triglycerides levels,metformin,placebo,continuous,,21,,23,194.3,63.1,181.8,61.3,0.19746629,0.09154041,,,,,Values seperated and found in table,TRUE,9637,7894,TEST,5779,"```yaml
intervention:
    mean: 44.3
    standard_deviation: 45.4
    group_size: 21
comparator:
    mean: 1.1
    standard_deviation: 43.3
    group_size: 23
```"
696,5639,5712123,morphine requirements,D group,P group,continuous,,30,,30,22.6,4.1,31.9,6.7,-1.6526241,0.08942639,,,,,found in fig3,TRUE,6401,5359,TEST,3891,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 30
comparator:
    mean: x
    standard_deviation: x
    group_size: 30
```"
527,6918,4411165,systolic BP,"whole-body to cold (whole-body cryostimulation, WBC)","whole-body except the head (partial-body cryostimulation, PBC)",continuous,,10,,10,,,,,cannot calculate,cannot calculate,,,,,Numerical values are only in the figures.,FALSE,3146,2589,TEST,2336,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 10
comparator:
    mean: x
    standard_deviation: x
    group_size: 10
```"
101,1886,4188762,heart rate,remifentanil,normal saline,continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 30
comparator:
    mean: x
    standard_deviation: x
    group_size: 30
```"
570,8558,5541727,Symptom improvement,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,,,,,cannot calculate,cannot calculate,,,,,Numerical values in figure.,FALSE,6118,5345,TEST,4032,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 11
comparator:
    mean: x
    standard_deviation: x
    group_size: 6
```"
135,2450,4574984,Health-Related Quality of Life at 12 month - males,"intervention group, i.e. patient empowerment through information booklet and diary keeping - males","control group, which received standard care - males",continuous,,216,,231,72.49,23.66,71.71,27.1,0.0305,0.009,,,,,Group sizes was inferred using Table of characterisitics. Back calculated SD using CI.,TRUE,12997,7944,TEST,5795,"```yaml
intervention:
  mean: 72.49
  standard_deviation: x
  group_size: 326
comparator:
  mean: 71.71
  standard_deviation: x
  group_size: 326
```"
198,7735,5380284,Surgery duration,Gum-chewing group,No gum group,continuous,,38,,37,,,,,cannot calculate,cannot calculate,,,,,Data is unavailable.,FALSE,1731,1429,TEST,1251,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 38
comparator:
    mean: x
    standard_deviation: x
    group_size: 37
```"
209,2913,5459456,inflexion-extension for the C2-C4 segments,ACVC-HA - artificial cervical vertebra and intervertebral complex (ACVC) with an HA biocoating or ACVC,control,continuous,,8,,8,4,0.3,4,0.6,1.9928,0.3741,,,,,,TRUE,13404,7477,TEST,5693,"```yaml
intervention:
  mean: 6.6
  standard_deviation: 0.9
  group_size: x
comparator:
  mean: 6.7
  standard_deviation: 1.1
  group_size: x
```"
239,8054,5534041,composite z-scores in autism spectrum disorder (ASD),right dorsolateral prefrontal cortex (DLPFC) anodal transcranial direct current stimulation (tDCS),sham stimulation,continuous,,12,,12,0.11,0.81,-0.25,0.71,0.4563,0.171,,,,,,TRUE,6951,5679,TEST,4357,"```yaml
intervention:
  mean: 0.11
  standard_deviation: 0.81
  group_size: 12
comparator:
  mean: -0.25
  standard_deviation: 0.71
  group_size: 12
```"
572,8561,5541727,medial tibial cartilage volume loss,Allogeneic mesenchymal precursor cells,Control,continuous,,11,,6,-1.4,4.2,-3.3,5.3,0.39232146,0.2621027,,,,,Values are from 24 months,TRUE,6118,5345,TEST,4032,"```yaml
intervention:
  mean: -1.4
  standard_deviation: 4.2
  group_size: 11
comparator:
  mean: -3.3
  standard_deviation: 5.3
  group_size: 6
```"
27,3244,2972614,Motion range - Shoulder adduction,Laser therapy (Group I),Placebo laser therapy (Group II),continuous,,30,,22,42,4.27,42.04,5.26,-0.0084,0.0788,,,,,Outcome originally just Motion range.,TRUE,7041,2968,TEST,1931,"```yaml
intervention:
    mean: 42.00
    standard_deviation: 4.27
    group_size: 30
comparator:
    mean: 42.04
    standard_deviation: 5.26
    group_size: 22
```"
106,1885,4188762,mean blood pressure,remifentanil,"normal saline, lidocaine, or ketamine",continuous,,30,,30,,,,,cannot calculate,cannot calculate,,,,,,FALSE,2068,1758,TEST,1564,"```yaml
intervention:
    mean: x
    standard_deviation: x
    group_size: 30
comparator:
    mean: x
    standard_deviation: x
    group_size: 90
```"
490,6383,3786549,Baseline characteristics: deliveries,Vaginal estriol plus viable Lactobacillus acidophilus KS400,Placebo,continuous,,44,,44,2.14,1.76,2.64,1.79,-0.2792152,0.04589751,,,,,,TRUE,9725,6231,TEST,4323,"```yaml
intervention:
  mean: 2.14
  standard_deviation: 1.76
  group_size: 44
comparator:
  mean: 2.64
  standard_deviation: 1.79
  group_size: 44
```"
